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7abstract 
Considerable evidence suggests that dietary macronutrients impact upon activities 
and conditions in the gastrointestinal tract (gIT) including: functions and processes, 
digestive enzymes secretion, microbial ecology and bacteria-derived metabolism. 
Knowledge about the modulation of canine intestinal microbiota, bacteria-derived 
metabolic	products,	intestinal	inflammatory	status	and	adaptive	exocrine	pancreatic	
secretion in response to macronutrients is limited. However, such information is 
necessary to investigate further the complex interplay between host and intestinal 
microbiota in response to changes of diet.
The reasearch for this PhD thesis focused upon the changes of the intestinal 
microbiota,	bacteria-derived	metabolic	products,	an	intestinal	inflammatory	marker	
and	pancreatic	enzyme	profiles	of	five	healthy	Beagle	dogs	in	response	to	being	fed	
three different diets: high-carbohydrate starch (HCS), high-protein greaves-meal 
(HPgM), or a balanced dry commercial (DC) diet. Every diet was crossed-over and 
fed to each dog for three 21-day periods.
	 The	microbial	 deoxyribonucleic	 acid	 (DNA)	was	 profiled	 according	 to	 its	
percentage	of	the	guanine-cytosine	content	(%G+C)	in	order	to	detect	the	fluctuations	
in intestinal microbiota. Thereafter, 16S ribosomal ribonucleic acid (16S rRNA) gene 
amplicons	were	obtained	from	the	most	abundant	%G+C	peaks	and	analysed	by	
sequence analysis. The DC diet sample was associated with high abundances of 
representatives of the orders Clostridiales, Lactobacillales, Coriobacteriales and 
Bacteroidales. Sequence diversity was highest for the DC diet samples and included 
representatives of the orders Lactobacillales and Bacteroidales, which were not 
detected in samples obtained for the HPgM and HCS diets. The HPgM and HCS 
diets also had reduced numbers of representatives of the family Lachnospiraceae; 
specifically	Clostridium cluster XIVa. The HCS diet favoured the proliferation of 
representatives of the order Erysipelotrichales,	specifically	the	Clostridium cluster 
XVIII, whereas the HPgM diet favoured representatives of the order Fusobacteriales.
Bacterial	metabolism	 and	 intestinal	 inflammatory	 status	were	 assessed	 by	
determining dry matter, pH, ammonia, short-chained fatty acids (SCFAs), and faecal 
canine calprotectin concentrations. Faecal ammonia concentrations decreased 
with the HCS diet. All dogs fed the HPgM diet developed diarrhoea, which led to 
differences in faecal consistency scores and increased faecal pH. Moreover, decreases 
in propionic and acetic acids coupled with increases in branched-chain fatty acids 
and valeric acid caused changes in faecal total SCFAs.  Faecal canine calprotectin 
concentration was also higher for the HPgM diet than with the other diets and 
correlated positively with valeric acid concentrations.
8Dietary	effects	on	digestive	enzyme	composition	in	the	serum,	in	jejunal	fluid,	
and in the faeces were studied by determining the following factors: amylase 
activity, the concentrations of canine trypsin-like immunoreactivity (cTLI), canine 
pancreatic lipase immunoreactivity (cPLI), and canine pancreatic elastase (cE1) 
concentrations with the two radioimmunoassays (RIAs) for determining cTLI and 
cPLI	concentrations	were	specifically	validated	for	jejunal	fluid	and	faecal	specimen	
analysis.	Both	RIAs	were	linear,	accurate,	precise,	and	reproducible.	Dog	specific	
serum enzyme concentrations did not differ between diets. Feeding the HCS diet 
was associated with decreased amylase activities and cPLI concentrations in the 
lower jejunum, when compared to the corresponding cPLI activities of the HPgM 
and the DC diet. The HPgM diet decreased the concentrations of cPLI and cE1 in 
faecal	samples,	but	not	in	the	jejunal	fluid.
In conclusion, all bacterial clusters discovered in this research represent the 
normal gIT microbiota of canines. The HPgM diet favoured Fusobacterium and 
this gram-negative bacterial genus may be associated with the observed elevated 
inflammation	status.	The	 latter	was	deduced	 from	the	observed	diarrhoea	and	
elevated levels of canine faecal calprotectin in all dogs fed the HPgM diet. It 
seems likely that these research results could be associated with the quality and 
increased or decreased amounts of dietary protein or carbohydrate being available 
for fermentation by the intestinal microbiota. The limited capacity of pancreatic 
enzymes	to	adapt	adequately	by	a	change	in	profile	in	response	to	changes	in	dietary	
components	seems	to	be	an	essential	factor,	which	influences	the	nutrient	levels	
available for the intestinal microbiota.
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abbrEviations
A-T Adenine-thymine
Bzero Counts per minute for the zero-standard
BCFAs Branched-chain fatty acids
bp base pair
Ca2+ Calcium
CFU Colony forming unit
CI	 Confidence	interval
CPM Counts per minute
CsCl Caesium chloride
cTLI Canine trypsin-like immunoreactivity
cPLI Canine pancreatic lipase immunoreactivity
cE1 Canine pancreatic elastase
CV	 Coefficient	of	variation
DC Dry commercial diet
DNA Deoxyribonucleic acid
dNTP Deoxyribonucleotide triphosphate
ELISA           enzyme-linked immunosorbent assay 
EPI	 Exocrine	pancreatic	insufficiency
FoS Fructooligosaccharide
g-C guanine-cytosine
gIT gastrointestinal tract
HClo4 Perchloric acid
H2S Hydrogen sulphide
HCS High-carbohydrate starch based diet
HPgM High-protein greaves-meal diet
IBD	 Inflammatory	bowel	disease
IFCC International Federation of Clinical Chemistry and Laboratory  
 Medicine
IgA Immunoglobulin A
125I Iodine-125
NH3 Ammonia
NSAID	 Non-steroidal	anti-inflammatory	drug
NSB	 Nonspecific	binding
o/E observed-to-expected ratios
oR odds ratio
Pfu Pyrococcus furosius
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PCR Polymerase chain reaction
Rho	 Rank	sum	correlation	coefficient
RIAs Radioimmunoassays
SCFA Short-chained fatty acids
S100A12 Calgranulin C
TE Tris-Ethylenediamineteraacetic acid
UV Ultraviolet
VFAs Volatile fatty acids
Wo Washout phase
Zn2+ Zinc
16S rDNA 16 S ribosomal deoxyribonucleic acid
16S rRNA 16 S ribosomal ribonucleic acid
18S rRNA 18 S ribosomal ribonucleic acid
%G+C		 Percentage	of	guanine	and	cytosine
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Introduction
1 introduction
The canine gastrointestinal tract (gIT) is a very complex microbial ecosystem that 
mainly consists of bacteria, but also includes different yeasts, moulds and viruses 
(Suchodolski et al. 2008a,b, 2011, 2012; Foster et al. 2013). Each dog has a unique 
and	stable	microbial	population	that	under	conditions	of	nutritional	sufficiency	can	
increase in numbers up to as high as 109 – 1011 colony forming units/g (CFU/g) 
in the colon (Simpson et al. 2002; Mentula et al. 2005; Suchodolski et al. 2008a). 
The colonic microbiota of dogs also has the most diverse population of all the 
intestinal segments and normally includes seven bacterial genera, i.e., Bacteroides, 
Clostridium, Lactobacillus, Bifidobacterium, Fusobacterium, Enterobacter and 
Coriobacterium  (Handl et al. 2011; Suchodolski 2011; Suchodolski et al. 2012). 
An important function of the colonic microbiota is the fermentative conversion 
of food and nutrients that had already escaped digestion and uptake by the host 
further upstream in the gIT. In the upper gIT, this upstream digestive process is 
highly complex and involves pancreatic enzymes and zymogens that are needed 
for the digestion and breakdown of dietary macromolecules such as protein, fat, 
carbohydrates in the small intestine. The composition of the dietary substrate 
i.e., chyme is what results after all the absorption processes have occurred. These 
processes mainly involve degradation by pancreatic enzymes and other digestive 
substances	 that	 influence	 the	 intestinal	microbiota,	bacteria-derived	metabolic	
products, and the health of the intestine and with this of the host. Alteration in the 
intestinal	microbiota	due	to	dietary	interventions	could	therefore	influence	intestinal	
health and also disease by playing a key role in the induction and maintenance of 
intestinal	inflammation	(Zoran	2003;	Zentek	et	al.	2004;	Hooda	et	al.	2013).	The	
intensity	and	extent	of	such	inflammation	could	be	detected	by	biomarkers	such	
as faecal canine calprotectin for which a radioimmunoassay (RIA) was developed 
and analytically validated by Heilmann et al. (2008a,b). 
Most of the data on the gIT were derived from human and animal model studies, 
which revealed that there are various additional factors at play. These additional 
factors include host-microbe interactions, colonization resistance, colonic transit 
time, intraluminal pH, intestinal mucus, production of immunoglobulin A, bile and 
bile	acids.	These	listed	additional	factors	 influence	the	composition	of	 intestinal	
microbiota and its metabolic products when fermenting nutrients (Stock-Damge 
et al. 1984; Ballesta et al. 1990; Mackie et al. 1999; Wong et al. 2006; James et al. 
2009; Salonen & de Vos 2014; Zoetendal & de Vos 2014). 
The fermentation of the dietary carbohydrates produces various essential 
substances such as short chain fatty acids (SCFAs), of which butyrate is the main 
energy source for the colonic epithelial cells, whereas acetate and propionate provide 
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energy for the brain, the heart and muscles as reported by mainly animal model 
studies (Cummings & Macfarlane 1991; Topping & Clifton 2001; Hooper et al. 
2002; McManus et al. 2002; Macfarlane & Macfarlane 2003; Wong et al. 2006; 
Salonen & de Vos 2014; Zoetendal & de Vos 2014). Conversely, the fermentation 
of protein mostly results in undesired metabolic end-substances such as phenols, 
ammonia, sulphur, though this depends on the amino acid content of the proteins 
(Macfarlane et al. 1986; Wong et al. 2006; Nyangale et al. 2012; Scott et al. 2012, 
Salonen & de Vos 2014). 
The majority of intestinal microbes have not yet been cultured in the best-
characterized human ecosystem (Rajilic-Stojanovic & de Vos 2014). Hence, 
molecular approaches are needed that obviate the need for culturing, such as 
those based on the 16S rRNA gene, which is used as a phylogenetic marker or 
metagenomic sequencing studies (Zoetendal et al. 2008). There are only a few 
studies in canine research, which have used 16S rRNA-based molecular methods 
for detecting the alterations in the composition of the canine intestinal microbiota 
in response to the composition and quantity of the diet (Suchodolski et al. 2008a, 
2009; garcia-Mazcorro et al. 2011; Wakshlag et al. 2011; Beloshapka et al. 2013). 
However, no studies have addressed the interplay of host and microbiota that result 
from changes of diets. The aim of this PhD research project was to add knowledge 
to	this	field	by	exploring	the	effect	of	high-protein	and	high-carbohydrate	diets	on	
canine faecal microbiota, their metabolic products, and the reaction of the host 
regarding	the	intestinal	inflammatory	state	and	adaptive	changes	of	the	pancreatic	
enzyme	profile	to	changes	in	diet.	Several	advanced	laboratory	methods	have	been	
used to achieve these aims and these include molecular methods to analyse intestinal 
microbiota, high performance liquid chromatography (HPLC) for assessing faecal 
fatty	acid	profiles	and	species-specific	radioimmunoassays	(RIAs)	to	determine	
canine	calprotectin	and	species-specific	pancreatic	enzyme	concentrations.
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2 rEviEw of thE litEraturE
2.1 IntestInal mIcrobIota
The gITs of animals and humans harbour very complex microbial ecosystems, that 
in addition to having populations of prokaryotes such as bacteria, methanogenic 
archaea, also comprise various different yeasts, viruses and moulds (Balish et al. 
1977; Hart et al. 2002; de Vos & de Vos 2012). These metabolically active intestinal 
microbes, is collectively termed microbiota and outnumber the body cells by a 
factor of 10 and have been shown to play an important role in the health of the 
host and also diseases that affect the host (Tancrede 1992; Batt 1996; Strombeck 
1996; Hart et al. 2002; de Vos & de Vos 2012). Humans and other animals are 
born in a virtually aseptic state, consequently the colonization by the intestinal 
microbiota starts at birth and results in a climax community that remains relatively 
stable over the host’s life (Benno & Mitsouka 1989; Buddington 2003a; Koenig 
et al. 2011; Ringel-Kulka et al. 2013; Nylund et al. 2014; Wopereis et al. 2014). 
Various hypotheses have been formulated to explain the colonization process and 
some of which have been reviewed recently (Scholtens et al. 2012; Nylund et al. 
2014;	Wopereis	et	al.	2014).	During	the	first	weeks	of	life	the	aerobes	predominate,	
but with aging more anaerobes will proliferate in the intestine (Benno et al. 1992; 
Buddington 2003a; Koenig et al. 2011). The gastrointestinal microbiota is relatively 
stable during adulthood (Buddington 2003a; Rajilic-Stojanovic et al. 2007), but 
it will become less diverse in the elderly, which is possibly due to the changing 
structure and functional properties of the gIT (Benno et al. 1992; Simpson et al. 
2002; Rajilic-Stojanovic et al. 2007; Claesson et al. 2009). 
It is generally assumed that the microbe-host interactions are mutualistic, thus 
both	the	bacteria	and	the	host	will	benefit	(Les	Dethlefsen	&	Relman	2007).	Intestinal	
bacteria are needed to maintain the health of the host as they are involved in the 
following complex mechanisms: of digestion of food, metabolism of endogenous 
and	exogenous	compounds,	production	of	vitamins,	detoxification,	prevention	of	
colonization by pathogenic microbes in the intestine, and the stimulation of the 
immune system (Table 1). 
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table 1. Importance of the intestinal microbiota.
Effects most relevant observations references
Digestion of food Bacteria encode various catabolic enzymes 
that degrade and ferment polysaccharides and 
glycans of dietary or host origin
Koropatkin et al. 2012
Production of 
vitamins
Bifidobacterium and Lactobacillus spp. are 
capable of producing folate
Various bacteria synthesize vitamin B12
Martens et al. 2002; 
Bertrand et al. 2011; Rossi 
et al. 2011
Metabolism 
of various 
compounds
Indoxyl sulphate and indole-3-propionic acid 
breakdown are mediated by the Clostridium 
spp.; Hydrogen sulphide production; Bile acid 
biotransformations by microbial enzymes
Lefebvre et al. 2009; 
Wikoff et al. 2009: 
Lagouette et al. 2010; 
Flannigan et al. 2011
Prevention of 
colonization 
by pathogenic 
bacteria
Commensal bacteria prevent pathogenic 
colonization by competing for attachment sites 
and nutrients, and also through the production 
and secretion of antimicrobials.
Tlaskalova-Hogenova et 
al. 2004; Ghoshal et al. 
2012
Enhancing the 
immune system
Emergence of T-cell subsets and differentiation 
of gut B cells into immunoglobulin A (IgA) – 
producing plasma cells; signal transduction and 
activation of the Toll-like receptors
Hooper & Gordon, 2001; 
Hart et al. 2002; Chung 
& Kasper 2010; Hooper 
& Macpherson 2010; 
Carvalho et al. 2012; 
Caricilli et al. 2014
Maintenance of 
general health 
and also mental 
health status
Bidirectional communication between the GIT 
and the central nervous system, the microbiota-
gut-brain axis; early-life colonization and 
microbiota development determine general and 
mental health in later life
Heijtz et al. 2011; Hsiao et 
al. 2013; Borre et al. 2014; 
de Theije et al. 2014 
The development and composition of the native microbiota influences the 
maturation of the gut-associated immune system (Benno et al. 1989; Buddington 
2003a; Koenig et al. 2011). The gIT is the largest immunological complex, thus 
disturbances in the intestinal microbiota, or in immune responses to its components 
would be expected to play a role in many health issues (Hart et al. 2002; Sekirov et 
al. 2010). It has been found that quantities of Escherichia coli (E. coli) and other 
Enterobacteriaceae in combination with a decreased levels of Faecalibacterium 
prausnitzii are associated with the Crohn`s disease in humans (Willing et al. 2009, 
2010; Varela et al. 2013; Kostic et al. 2014), Clostridium and Fusobacterium spp. 
are associated with colorectal cancer (Scanlan et al. 2008; Castellarin et al. 2012; 
Kostic et al. 2012), and Helicobacter pylori is associated with gastric cancer (Correa 
& Houghton 2007). It has also been observed that Fusobacterium spp. could be 
related	to	acute	appendicitis	(Swidsinski	et	al.	2011)	and	to	other	 inflammatory	
processes in various anatomical regions such as the colon, oropharynx, gingiva, 
periodontium (Citron 2002; ohkusa et al. 2009). In dogs, Proteobacteria have been 
linked	with	inflammatory	bowel	disease	(IBD)	(Xenoulis	et	al.	2008;	Suchodolski	
et al. 2010). Adherent and invasive E. coli strains have been associated with 
intestinal	inflammation	in	Boxer	dogs	with	histiocytic	ulcerative	colitis	(Simpson	
et al. 2006). Increased levels of Clostridium perfringens and decreased levels of 
Bifidobacterium have been associated with the development of loose faeces (Zentek 
17
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et al. 2003; Zentek et al. 2004), and Fusobacterium spp. could be associated with 
the periodonditis and ulcerative keratitis (Ledbetter & Scarlett 2008; Senhorinho 
et al. 2012; Khazandi et al. 2014). In most of the cases it is unknown, whether the 
changes	in	the	intestinal	microflora	are	the	causative	agent	or	are	the	consequence	
of the disease. Further, many enteropathogens including E. coli, Salmonella spp. 
are present in both diseased and healthy animals (Queen et al. 2012). Causality has 
been demonstrated in recent human studies for metabolic syndrome and recurrent 
infection of Clostridium difficile (Vrieze et al. 2012; van Nood et al. 2013) with the 
use of faecal transplantation, which is a useful but imperfect method in humans 
(de Vos 2013).
2.1.1 canIne IntestInal mIcrobIota
Although most studies have been reported on human microbiota, there is no reason 
to assume that the basic properties and processes are different for animals. Dogs 
and humans have rather similar gastrointestinal anatomy and physiology, dietary 
pattern, metabolic processes and intestinal disease aetiologies, which in turn makes 
a dog effective as a model for human intestinal health and disease and vice versa 
(Swanson & Shook 2006; Swanson et al. 2011). Most pet dogs are now treated as 
full family members, who not only live in the home, but also eat, play and sleep 
together with their owners. A recent paper described the transfer of dog microbes 
from skin to their cohabiting owners (Song et al. 2013). 
The research studies in this thesis deals with the effects of diet on dogs, the salient 
features	of	the	canine	microbiota	will	be	briefly	summarized	here.	The	bacterial	
quantities in dogs vary between different sites of the gIT namely: the stomach, small 
intestine and colon. These are similar to those of humans. The stomach contains 
lower numbers of bacterial population due to the acidic environment, which is not 
favourable for many bacteria. The upper part of the small intestine also contains 
lower numbers of microorganisms compared to the distal parts of the intestine, 
which is probably due to the more acidic environment from gastric acid, bile acid 
and to the action of peristalsis of the gut (Batt 1996). The stomach contains 101 – 106 
CFU/g of bacteria, whereas the duodenal and jejunal bacterial loads vary between 
individuals range from less than 103 up to 109 CFU/g in some dogs. The more distal 
parts of the small intestine such as i.e., ileum contain bacteria at levels of 107 CFU/g 
and the colon 109 – 1011 CFU/g (Benno et al. 1992; german et al. 2003; Mentula 
et al. 2005; Suchodolski 2011). The number of bacteria in the colon is the highest 
since this part of the gIT has a large diameter that results in a slow transit of the 
undigested food, which results in a low redox potential and anaerobiosis, colonized in 
large numbers by obligate anaerobes (over 99%) and to a lesser extent by facultative 
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anaerobes (Balish et al. 1977; Cummings & Macfarlane 1991; Batt 1996; Berg 1996; 
Mackie et al. 1999; Simpson et al. 2002; guarner & Malagelanda 2003). In the study 
carried out by Simpson et al. (2002) the aerobic bacteria counts in the canine large 
intestine were one-twentieth that of the anaerobic bacteria with levels of 4 x 1010.
It is known, that each dog has a unique characteristic composition of the 
intestinal microbiota, but the main groups of bacteria are common for all dogs 
(Balish et al. 1977; Simpson et al. 2002). The quantity of the intestinal bacteria 
differs between different parts of intestine. The same could also be said for the 
differences between the composition of the intestinal microbiota and faeces because 
the bacteria present in the faeces of dogs were found to be distinctly different from 
the bacterial composition of the small intestine (Mentula et al. 2005; Suchodolski 
et al. 2008a). Increased diversity of microbes occurs in the colon as compared to 
the other segments of the gIT (Mentula et al. 2005; Suchodolski et al. 2008a). 
Culturing studies indicated that acid-resistant species such as clostridia, lactobacilli, 
E. coli, streptococci and yeasts are the predominant microorganisms in the upper 
part of the gut in dogs (Batt 1996; Strombeck 1996; Mackie et al. 1999), whereas 
coliforms (E. coli), enterococci, lactobacilli, Bacteroides spp., and bifidobacteria	are	
present in the jejunum and ileum (Holzapfel et al. 1998; Johnston 1999). In addition, 
cultivation	studies	have	shown	that	the	jejunum	and	colon	are	significantly	different	
in	regard	to	the	ratio	of	aerobic	versus	anaerobic	bacteria	they	contain.	Specifically,	
the jejunum has quite equal ratios of aerobes to anaerobes, but the colon favours an 
anaerobic bacterial population that remains relatively constant over a certain time 
period under the same environmental conditions (Mentula et al. 2005). 
The knowledge about the composition of the canine intestinal microbiota had 
been obtained from the culturing studies of faeces for many years. Nowadays, it is 
well	recognized	that	currently	used	cultivation	methods	do	not	provide	sufficient	
information about the microbial composition due to certain limitations: the 
optimal growth requirements of most microorganisms are not known in detail, the 
predominant anaerobic bacteria may be more prone to inactivation during sample 
handling, and there are so many different species that culturing all of them need 
considerable amounts of manpower. Most microbes live in mutualistic interactions 
with other microorganisms or the host, which could further slow their growth on 
culture media (greetham et al. 2002; Suchodolski 2011). In a recent study, most 
of the gut microbes in humans could not be cultured (Rajilic-Stojanovic & de Vos 
2014). Therefore, molecular approaches are required. Knowledge about the canine 
intestinal microbiota still lags behind that of humans, but recently new data were 
reported. These data were obtained through improvements in methodologies 
such as the reduced cost of pyrosequencing and other next-generation sequencing 
techniques	 (Suchodolski	 et	 al.	 2009).	 The	 first	 comprehensive	 and	 culture-
independent study that described the intestinal microbiota at sites that ranged from 
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the duodenum to the colon was based on analysis of cloned libraries (Suchdolski et 
al. 2008a). That study showed that Fusobacteriales and Bacteroidales accounted for 
approximately 25-30% of the clones, each clone was most abundantly represented 
in the canine colon.  Firmicutes were also found to co-dominate the colon of healthy 
dogs (Middelbos et al. 2010). In addition, Clostridiales (approximately 40% of 
clones) and Enterobacteriales (approximately 30% of clones) predominated in 
the duodenum and jejunum, whereas Lactobacillales were found in all parts 
of the intestine (Suchodolski et al. 2008a). A study reported by Xenoulis et al. 
(2008) concluded that the following six phyla were presented in the duodenums of 
healthy control dogs: Firmicutes (47% of clones), Proteobacteria (27% of clones), 
Bacteroidetes (11% of clones), Spirochaetes (10% of clones), Fusobacteria (4% of 
clones), and Actinobacteria (1% of clones). 
A pyrosequencing study of the faecal microbiota of healthy dogs conducted by 
Middelbos et al. (2010), reported a predominance of the phyla Firmicutes (15 to 
28% of sequences), Bacteroidetes (32 to 34% of sequences), Fusobacteria (24 to 
40% of sequences), Actinobacteria (0.8 to 1.4% of sequences), and Proteobacteria 
(5 to 6% of sequences). Subsequently, various studies have reported data for faecal 
microbial populations of healthy pet and laboratory dogs measured using 454 
pyrosequencing (garcia-Mazcorro et al. 2011; Handl et al. 2011; Suchodolski et al. 
2012; Beloshapka et al. 2013; Hand et al. 2013). Seven bacterial groups (Bacteroides, 
Clostridium, Lactobacillus, Bifidobacterium, Fusobacterium, Enterobacteriaceae 
and Coriobacterium)	 in	 five	 predominant	 phyla	 (Firmicutes, Fusobacteria, 
Bacteroidetes, Proteobacteria and Actinobacteria)	have	been	identified	from	the	
canine gastrointestinal tract, which have been summarized in Table 2. Although 
the predominant phyla are the same, the proportions vary greatly from dog to dog 
within the same study (Suchodolski et al. 2004) and among different studies. 
Some	contradictory	findings	have	been	reported	for	the	presence	of	bifidobacteria	
as in one study it was undetectable (greetham et al. 2002), whereas in other cultured-
based sequencing studies that used 16 S ribosomal ribonucleic acid gene (16S rRNA) 
as a marker, Bifidobacterium was found to be a member of the normal canine 
intestinal microbiota (Buddington 2003a; Mentula et al. 2005; Handl et al. 2011; 
Beloshapka et al. 2013). However, it is known that this group of the Actinobacteria 
requires	specific	primers	to	amplify	its	16S	rRNA	marker	and	hence	this	may	be	the	
source of a technical bias associated with the methodology as has been described 
in one human study (Ringel-Kulka et al. 2013). 
Several	recent	studies	have	identified	distinct	intestinal	microbial	populations	in	
dogs with IBD and other enteropathies. These are all summarized in detail in Table 2.
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table 2. Main bacterial groups found in the canine gut by 16 S ribosomal ribonucleic acid gene sequencing-
based studies. 
sample 
material
breed and health 
status of the host
method microbial 
alterations
references
Samples 
from 
duodenum 
up to 
colon
Healthy Hound 
dogs
Comparative 16S 
rRNA gene analysis 
from clone libraries
Small intestine: 
Clostridiales, 
Enterobacteriales
Colon: Firmicutes, 
Bacteroidetes, 
Fusobacteria
All parts: 
Lactobacillales
Suchodolski et al. 
2008a
Duodenal 
brush 
samples
Different breeds of 
dogs,
Inflammatory 
bowel disease
Comparative 16S 
rRNA gene analysis 
from clone libraries
Increase  in E. coli
Decrease in 
microbial diversity:
Firmicutes
Proteobacteria
Bacteroidetes
Spirochaetes
Fusobacteria
Actinobacteria
Xenoulis et al. 
2008
Jejunal 
mucosal 
brush 
samples
Beagles, tylosin-
administration
Pyrosequencing 
of 16S rRNA 
amplicons
Decrease in 
Fusobacteria, 
Bacteroidales and 
Moraxella
Increase in 
Enterococcus-
like organisms, 
Pasteurella spp., 
Dietzia spp.
Suchodolski et al. 
2009
Duodenal 
brush 
samples
German 
Shepherd, food-, 
or antibiotic-
responsive 
diarrhoea
Comparative 16S 
rRNA gene analysis 
of clone libraries
Increase in 
Streptococcus and 
Moraxella spp.
Allenspach et al. 
2010
Duodenal 
biopsies
Different breeds of 
dogs,
Inflammatory 
bowel disease
Pyrosequencing 
of 16 S rRNA 
amplicons
Increase in 
Proteobacteria, 
Decrease in 
Clostridium cluster 
XIV and V (i.e., 
Faecalibacterium, 
Ruminococcus, 
Dorea spp.)
Jergens et al. 
2010
Duodenal 
biopsies
Different 
breeds of dogs, 
Inflammatory 
bowel disease
Comparative 16S 
rRNA gene analysis 
of clone libraries
Increase in 
Proteobacteria, 
Decrease in 
Clostridia (class)
7 phyla detected:
Proteobacteria
Firmicutes
Bacteroidetes
Actinobacteria
Fusobacteria
Tenericutes
Verrucomicrobia
Suchodolski et al. 
2010
Faeces Mongrels and 
Hound-cross dogs, 
healthy
Pyrosequencing 
of 16S rRNA 
amplicons 
Fusobacteria 
Firmicutes 
Bacteroidetes
Middelbos et al. 
2010
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Faeces Different breed 
of healthy 
dogs, synbiotic 
administration
Pyrosequencing 
of 16S rRNA 
amplicons 
Probiotic species 
detectable in 10/12 
dogs
Increases in 
Enterococcus and 
Streptococcus spp.
No change in 
major phyla
Garcia-Mazcorro 
et al. 2011
Faeces Different breeds of 
healthy dogs
Pyrosequencing 
of 16S rRNA 
amplicons 
Firmicutes
Bacteroidetes
Clostridia (class) 
Clostridium cluster 
XIV and XI and 
Ruminococcus 
Handl et al. 2011
Faeces Hound-cross dogs, 
healthy
Pyrosequencing 
of 16S rRNA 
amplicons 
Bacteroidetes
Firmicutes
Proteobacteria
Fusobacteria
Swanson et al. 
2011
Faeces Different breed 
healthy pet dogs
Pyrosequencing 
of 16S rRNA 
amplicons 
Firmicutes
Actinobacteria
Proteobacteria
Fusobacteria
Acidobacteria
Garcia-Mazcorro 
et al. 2011
Faeces Beagles, healthy Pyrosequencing 
of 16S rRNA 
amplicons 
Fusobacteria
Firmicutes
Bacteroidetes
Proteobacteria
Beloshapka et al. 
2013
Faeces Miniature 
Schnauzers, 
healthy
Pyrosequencing 
of 16S rRNA 
amplicons 
Fusobacteria
Bacteroidetes
Firmicutes
Proteobacteria
Hand et al. 2013
16S rRNA = 16 S ribosomal ribonucleic acid
Further,	molecular	fingerprinting	has	demonstrated	that	each	dog	has	a	unique	
and stable microbial ecosystem (Simpson et al. 2002; Suchodolski et al. 2005). All 
animals harbour similar bacteria at family or genus level, but the microbiome of 
each animal differs substantially on a species level. There was approximately only 
20% overlap of bacterial species between individual animals reported in a recent 
study (Handl et al. 2011). That same study also showed that a small percentage 
(<30%) of the dogs harboured the same species of Bifidobacterium spp. in their gIT.
It	is	known,	that	the	taxonomic	positions	of	the	involved	bacteria	are	not	sufficient	
to analyze the host-microbe interaction. The functionality of the intestinal microbiota 
needs to be investigated in order to understand the host-microbe interaction better. 
New high-throughput sequencing techniques facilitate rapid sequencing of total 
genomic	DNA	or	rRNA	without	the	need	for	prior	amplification	of	specific	genes	
(Suchodolski	2011).	In	addition	to	the	phylogenetic	identification	of	microorganisms,	
it is possible to obtain information about the gene content (metagenomics) or 
the expressed genes (transcriptomics or proteomics) from the microbial genome 
(microbiome).	Therefore,	it	is	possible	to	define	the	valuable	functional	capacity	of	
the microbial genome (Suchodolski 2011; Swanson et al. 2011). A study conducted 
by Swanson et al. (2011) revealed the most prevalent functional categories ascribed 
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to the canine intestinal microbiome, which were: carbohydrate utilization (up to 
13% of sequences), protein metabolism (up to 9%), DNA metabolism (7%), cell wall 
and capsule biosynthesis (up to 8%), virulence (7%), and production of cofactors, 
vitamins, and pigments (6%). The same study also concluded that the canine 
metagenome consists of sequences of bacteria (98%), fungi (0.4%), archaea (1%), 
and viruses (0.3 to 0.4%). 
Archaea belonging to two phyla, Crenarchaeota and Euryarchaeota, were 
identified	in	the	faeces	of	dogs	(Suchodolski	2011;	Swanson	et	al.	2011)	but	data	on	
relative proportions of each phylum are lacking. The duodenal contents of healthy 
dogs contain fungi that belong to the phyla of Ascomycota and Basidiomycota 
(Suhcodolski et al. 2008b). More recently, the fungal community was examined 
using 18S ribosomal ribonucleic acid (18S rRNA) gene pyrosequencing, which 
detected sequences in canine faecal samples that predominantly belonged to 
two fungal phyla: high proportions of Ascomycota (Saccharomyces as the most 
abundant genera) and Neocallimastigomycota to a lesser extent (Handl et al. 
2011; Suchodolski 2011; Suchodolski et al. 2012). Furthermore, a study carried 
out	by	Foster	et	al.	(2013)	indentified	five	distinct	fungal	phyla	in	the	canine	faeces	
namely: (Ascomycota, Basidiomycota, Chytridiomycota, Neocallimastigomycota, 
and Microsporidia), with Ascomycota and Basidiomycota being the most abundant 
fungal phyla. Candida, were detected on a species level as Candida natalensis, which 
was the most abundant genus found in dogs with diarrhoea and in healthy dogs.
Therefore, for a better understanding the host per se, microbial-host interactions 
in health and disease, the functionality of the intestinal microbiome needs to be 
explored as it gives us the crucial and valuable information about the metabolic 
functions of metagenomics, transcriptomics and proteomics of the intestinal 
microbiome (Suchodolski 2011; Swanson et al. 2011).
2.2 effects of dIet on the gastroIntestInal    
 mIcrobIota, metabolItes and Inflammatory   
 marker of companIon anImals
Several factors affect the host-microbe interactions apart from the bacterial species. 
These other factors play a role in the health status of the host and aetiology of 
the disease, they include: the host species age, the host`s susceptibility to disease, 
adherence	of	microbes,	the	colonization	resistance	of	the	specific	bacterial	species,	
the dietary substrate available for the bacterial usage, environmental conditions, 
geographical locality, intestinal motility patterns, medication history (Benno et al. 
1992; Ewing & Cole 1994; Kirjavainen & gibson 1999; Buddington 2003a; Noverr 
& Huffnagle 2005; Sekirov et al. 2010; Koenig et al. 2011; Scholtens et al. 2012; 
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Schwartz et al. 2012). In other words, it may be possible to promote the health of 
the host by inhibiting the growth of harmful bacteria and by stimulating the immune 
system	towards	beneficial	pathways	by	feeding	specific	diets	(Gibson	&	Roberfoid	
1995; ottman et al. 2012; Salonen & de Vos 2014). 
Although the results described above were derived from human studies, it has 
also been established that the main changes in intestinal microbial groups in dogs 
are	influenced	by	dietary	modifications	that	range	from	the	suckling	of	milk	to	eating	
solid pellets (Buddington 2003a; Buddington et al. 2003b). Intestinal microbial 
groups	are	also	influenced	by	the	ability	of	the	host	to	metabolize	dietary	substrates	
(Buddington 2003a; Buddington et al. 2003b). Commercial companion animal 
foods vary widely in macronutrient distribution, with extruded diets being rich in 
carbohydrate that range from 30 to 60% of diet on a dry matter basis (Hill et al. 
2009) In contrast, canned diets are more similar to wild-type and raw meat diets 
that contain less carbohydrate (<10% on a dry matter basis) and which have a 
higher protein and fat content than extruded formulations (Hill et al. 2009; Kerr 
2012a; Kerr et al. 2012b, 2013).
Salonen & de Vos (2014) recently reviewed diet-related mechanisms that affect 
the composition and the activity of the human intestinal microbiota such as intestinal 
transit rate, luminal pH, the amount of ingested fermentable polysaccharides and 
the production of SCFA, production of bile and bile acids, mucins secreted from 
goblet cells, gastric acid, pancreatic enzymes, secretory IgA, host gene expression. 
The pH of the luminal contents has an enormous impact on the composition of 
intestinal microbiota. For example, Enterobacteriaceae numbers increase with 
the increase in intestinal pH (Zimmer et al. 2012).  Acid suppressant therapy for 
atrophic gastritis led to an increase in small intestinal bacterial counts in humans 
(Zimmer et al. 2012; Zoetendal & de Vos 2014). The intestinal motility is also an 
important regulator of bacterial counts, because those bacteria that are not able 
to adhere to the epithelium will be eliminated. The lower the colonic transit time 
of the intestinal contents the higher are the numbers and diversity of intestinal 
bacteria (Kashyap et al. 2013; Zoetendal & de Vos 2014). The dietary substrate 
(i.e., chyme) is available after the digestion and degradation by pancreatic enzymes 
and	other	digestive	substances	and	influences	the	bacterial	fermentation	process.	
The bacterial fermentation, in turn, is dependent on the available substrate and 
the bacteria involved in the fermentation process (geypens et al. 1997; Mackie et 
al. 1999; Wong et al. 2006; Salonen & de Vos 2014; Zoetendal & de Vos 2014). 
The research for this thesis mostly aimed at investigating the effect of high-protein 
and high-carbohydrate diets on the faecal microbiota, their metabolism and host 
effects	such	as	the	adaption	of	pancreatic	enzyme	profiles	and	the	association	with	
intestinal	inflammation	to	dietary	changes.
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2.2.1 adaptatIon of the exocrIne pancreas and the    
 laboratory determInants of pancreatIc enzymes
The pancreas consists of an endocrine portion (up to 5% of the entire pancreas) 
and an exocrine part (up to 95% of the entire pancreas). The exocrine pancreas is 
responsible for the synthesis, storage, and release of various substances namely: 
bicarbonate-rich	fluid,	digestive	enzymes	such	as	amylase,	lipase,	trypsin,	elastase;	
inactive preforms of digestive enzymes such as trypsinogen, chymotrypsinogen, 
proelastase; and other co-factors such as colipase, intrinsic factor (Pandol 2010). 
The pancreatic enzymes and zymogens are needed for the digestion and breakdown 
of dietary macromolecules i.e. protein, fat, carbohydrates in the small intestine 
in order for them to be available for fermentation by the bacteria of the colon. 
Different	digestive	enzymes	are	needed	for	the	digestion	of	specific	nutrients	and	
the release of these enzymes from the pancreas change in proportion to the amounts 
of dietary carbohydrates, proteins, and fats that are present in the upper small 
intestine	(Kern	et	al.	1987;	Brannon	1990;	James	et	al.	2009).	Adequate	and	efficient	
adaptation of the exocrine pancreas to the diet is crucial for the host and intestinal 
bacteria, both need nutrients and energy for metabolism to live. The adaptation 
of exocrine pancreatic secretions to nutritional changes has been investigated in 
various species, especially rats (Stock-Damge et al. 1984; Chowdhury et al. 2000; 
Li et al. 2004; Lee et al. 2006). Research on the relationship between nutritional 
substrates and the secretion of pancreatic enzymes over the last three decades has 
scarcely been conducted in dogs and the few studies that were done focused mostly 
on	the	influence	of	dietary	fat	on	canine	exocrine	pancreatic	function	(Stock-Damge	
et al. 1984; Ballesta et al. 1990; Manas et al. 1996; Yago et al. 1997; James et al. 
2009). The knowledge about the correlation between the quantities of different 
macronutrients and pancreatic adaptation in dogs is limited (Buddington et al. 
2002).	A	study	performed	by	Manas	et	al.	(1996)	investigated	the	influence	of	fat	
or carbohydrate enriched diets on the adaptation of the exocrine pancreas in dogs 
over eight-day periods but it did not detect any adaptation of pancreatic secretions 
in the short-term. James et al. (2009) concluded that the serum canine trypsin-like 
immunoreactivity (cTLI) and canine pancreatic lipase immunoreactivity (cPLI) 
concentrations were not affected by the dietary fat, supplemented oral pancreatic 
enzymes or medium-chain triglycerides. Various other studies that used rats, pigs, 
and also dogs, on the other hand, showed increased amylase activity in the acinar 
cells and the pancreatic juice that occurred when feeding a carbohydrate-rich diet for 
periods of seven days, four weeks, or 48 weeks (Johnson et al. 1977; Poort & Poort 
1981; Stock-Damge et al. 1984; Flores et al. 1988; Takaori et al. 1995; Chowdhury 
et al. 2000; Lee et al. 2006). 
The	adaptation	of	the	exocrine	pancreas	is	influenced	by	the	amount	and	type	of	
the dietary macronutrients and the length of the feeding in days. A study reported 
a two-fold greater response of lipase to unsaturated fats over that for saturated fats 
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in pigs (Deschodt-Lanckman et al. 1971). However, Saraux et al. (1982) found that 
the	length	of	the	fatty	acid	chain	is	the	most	crucial	factor	as	it	influences	lipase	
activity	in	the	pancreatic	fluid.	Feeding	a	diet	rich	in	carbohydrates	and	fat	for	eight	
days revealed no changes in the expression and secretion of pancreatic lipase in 
pancreatic juice of dogs (Manas et al. 1996), whereas feeding a diet containing 8% 
sunflower	oil	for	32	weeks	led	to	an	increased	secretion	of	lipase	into	the	pancreatic	
juice	(Ballesta	et	al.	1990).	One	study	in	rats	concluded	that	it	took	up	to	five	days	
for the rat exocrine pancreas to adapt to a protein-rich diet, whereas 10 days were 
needed to adapt to a carbohydrate-rich diet (Lahaie & Dagorn 1981). 
Laboratory determinations of canine pancreatic enzymes can be performed by 
different	and	often	species	specific	assays.	 	Amylase	assay	kits	measure	amylase	
activity	in	various	fluids	such	as	jejunal	fluid.	In	recent	years	canine-specific	assays	
for the measurement of serum cTLI, cPLI, and faecal canine pancreatic elastase (cE1) 
concentrations have been developed and validated for assessing exocrine pancreatic 
function in dogs (Willams & Batt 1988; Lorentz 1998; Spillmann et al. 2000; Steiner 
& Williams 2003). The cTLI analyte indicates the combined concentrations of 
trypsinogen, trypsin and some trypsin molecules bound to protease inhibitors, 
whereas the cPLI analyte determines the lipase, which originates from pancreatic 
acinar cells. Both, the cTLI and cPLI analytes measured originate exclusively from the 
exocrine	pancreas	and	reflect	the	amount	of	functional	pancreatic	tissue	(Williams	
& Batt 1988; Steiner et al. 2006). The serum cTLI concentration is considered to be 
the diagnostically the most accurate variable for a diagnosis of exocrine pancreatic 
insufficiency	(EPI)	as	it	has	been	reported	to	be	significantly	decreased	with	this	
disorder (Williams & Batt 1988; Wiberg et al. 1999; Battersby et al. 2005).  However, 
James et al. (2009) showed that serum cTLI concentrations were unaffected by 
different diets, which indicated that serum cTLI lacks sensitivity to detect changes 
in exocrine pancreatic secretion by diets of different compositions in dogs. Although 
serum	cTLI	 is	specific	 for	detecting	exocrine	pancreatic	 insufficiency	(EPI),	 the	
serum	cPLI	concentration	is	only	specific	for	pancreatitis	(Steiner	et	al.	2006,	2008;	
Neilson-Carley et al. 2011). No alteration of serum cPLI was in response to different 
diets in healthy dogs was reported (James et al. 2009).
Pancreatic cE1 has been determined successfully in faeces and in serum with 
a	validated	dog-specific	enzyme-linked	immunosorbent	assay	(ELISA).	Decreased	
faecal cE1 concentrations are indicative of EPI and elevated serum cE1 values for 
acute	pancreatitis	(Spillmann	et	al.	2000;	Mansfield	2013).	However,	dogs	without	
EPI can also have decreased faecal cE1 concentrations (Spillmann et al. 2000; 
Wiberg et al. 2000, Steiner et al. 2010). The reason for this phenomenon is largely 
unknown. one study in affected dogs concluded a decreased pancreatic stimulation 
by cholecystokinin as one possible reason (Steiner et al. 2010).
Specific	pancreatic	enzymes	can	be	analyzed	by	radioimmunoassays	(RIAs)	
or ELISA, which are immunological methods with a high analytical sensitivity. 
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However, both methods have their disadvantages with respect to each other.  The 
ELISA methods usually have higher sensitivity compared to RIAs, whereas RIAs 
are easier to control and standardize. The disadvantage of using RIAs is that this 
method involves special equipment and the use of radioactive tracers that require 
special	precautions.	On	the	other	hand,	there	is	no	need	for	purification	using	RIAs,	
and the small volumes of heterologous antiserum used are important advantages 
of RIAs. ELISA methods, in turn, usually require large amounts of antienzyme 
antibodies (Heilmann et al. 2011a,b).
2.2.2 fermentatIon of dIetary carbohydrates, IntestInal   
 mIcrobIota and scfas
Carbohydrates	 can	be	 classified	as	monosaccharides	 such	as	glucose,	 fructose,	
galactose	 and	 also	 as	 disaccharides	 and	polysaccharides	 such	 as	 starch,	 fiber,	
glycogen and dextrins. The dietary carbohydrates, which are not degraded in the 
proximal	intestine	including	resistant	starches,	plant-origin	fiber	together	with	the	
unabsorbed sugars and sugar alcohols, are the major carbon-, hydrogen-, oxygen 
-and energy-containing constituents for large intestinal bacteria (Cummings & 
Macfarlane 1991; Macfarlane & Macfarlane 2003; Wong et al. 2006; Salonen & de 
Vos 2014; Zoetendal & de Vos 2014). 
The fermentation of the carbohydrates such as polysaccharide, oligosaccharide 
that enter the large intestine mostly takes place in the proximal colon, and 
predominantly produces short-chain fatty acids (SCFAs), such as acetate, propionate, 
butyrate, and also succinate and lactate but to a lesser extent. Acetate, propionate 
and butyrate form more than 85% of the total SCFAs produced in dogs (Cummings 
& Macfarlane 1991; Topping & Clifton 2001; Hooper et al. 2002; McManus et al. 
2002; Macfarlane & Macfarlane 2003; Wong et al. 2006; Salonen & de Vos 2014; 
Zoetendal & de Vos 2014).
The SCFAs provide energy for the host, which is crucial for various tissues 
as acetate and propionate provide energy for brain, heart and muscles; whereas 
butyrate is the main energy source for the colonic epithelial cells (Roediger 1982; 
Cummings et al. 1987; Bergman 1990; gill & Rowland 2002; Montagne et al. 2003; 
Wong	et	al.	2006;	Salonen	&	de	Vos	2014).	Butyrate	also	influences	the	regulation	
of	cell	proliferation	and	differentiation,	and	has	anti-inflammatory	properties	and	is	
suggested to lower the risk of colon cancer (Williams et al. 2003; Wong et al. 2006; 
Blaut & Clavel 2007; Tedelind et al. 2007; Toden et al. 2007a,b; Vinolo et al. 2009). 
It is known, that certain prebiotics such as fructo-oligosaccharides, lacto-sucrose, 
and inulin increase colonic butyrate levels (Terada et al. 1992; Campell et al. 1997; 
Le Blay et al. 1999; Swanson et al. 2002; Licht et al. 2006; Rehman et al. 2008). 
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The lack of butyrate production or absorption contributes to the development of 
ulcerative	colitis	and	other	inflammatory	conditions	by	causing	a	deficiency	of	energy	
in the intestinal epithelial cells. There is evidence that increasing the amount of 
dietary	fiber	increases	the	concentration	of	butyrate	in	the	lumen,	which	may	be	
an appropriate means of ameliorating symptoms of certain IBDs (Wachtershauser 
& Stein 2000). Furthermore, butyrate is more effective than acetate or propionate 
in enhancing Na+ absorption (Roediger & Moore 1981). This mechanism is of 
considerable	importance	in	limiting	fluid	losses	in	acute	diarrhoeal	illnesses	that	
are	primarily	characterized	by	small	intestinal	fluid	secretion	(Ramakrishna	1996).	
Butyrate is mainly produced by the bacterial members of the Clostridium cluster 
XIVa, which includes Roseburia spp., Eubacterium rectale and also cluster IV, which 
includes Faecalibacterium spp. In contrast, Anaerostipes caccae and Eubacterium 
hallii are capable of converting lactate and acetate into butyrate (Barcenilla et al. 
2000; Pryde et al. 2002; Duncan et al. 2007; Louis et al. 2010; Bui et al. 2014).
Acetate is used for lipogenesis and cholesterol synthesis, whereas propionate 
is a substrate for hepatic gluconeogenesis. Acetate is mostly utilized by butyrate-
producing bacteria, which require acetate for their optimal growth (Wong et al. 2006; 
Vipperla & o´Keefe 2012).  The requirement for acetate in lipogenesis is considered 
to be an obesity factor in humans (Fernandes et al. 2014; Salazar et al. 2014). 
Acetate is mostly produced from polysaccharides by the action of Streptococcus 
spp. (Zoetendal et al. 2012).
Valeric acid is implicated in having some negative nutritional effects as it has 
been reported to inhibit biotin uptake by colonocytes in humans (Said et al. 1998). 
Biotin is needed for fatty acid biosynthesis, gluconeogenesis, and the catabolism of 
several branch chain fatty acids (BCFAs) (Sweetman & Nyhan 1986; Dakshinamurti 
&	Chauhan	1988).	In	addition,	significantly	higher	levels	of	faecal	acetic,	i-butyric,	
valeric acids, and total SCFAs were found in children with ceoliac disease (Tjellström 
et al. 2005). An increase in valeric acid concentrations were reported for humans 
after eating a diet that incorporated supplemental dietary protein comprising whey, 
casein, and lactalbumin (geypens et al. 1997). This increase was probably due to 
the catabolism of amino acids by the proteolytic bacteria, including Fusobacteria, 
as reported recently by Resmer & White (2011).
Changes	in	SCFA	profiles	were	also	seen	in	infants	with	allergy	conditions,	for	
whom lower levels of propionic, isobutyric, butyric, isovaleric, and valeric acids 
were detected (Böttcher et al. 2000). The authors of that same study suggested 
that	the	altered	SCFA	profiles	indicated	differences	in	intestinal	microbiota,	which	
may	influence	the	development	of	a	normal	immune	system	in	allergic	children.
Carbohydrate fermentation also results in the production of variable 
amounts of hydrogen, carbon dioxide and heat. Hydrogen has an inhibitory 
impact on fermentation, whereas at the same time it could be used by a variety 
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of bacteria including: reductive acetogens, i.e. Blautia spp.; methanogens, i.e. 
Methanobrevibacter smithii; and sulphate reducers, i.e. Desulfovibrio spp. as an 
energy source (Flint et al. 2012; Zoetendal & de Vos 2014).
The	impact	of	dietary	fiber	and	prebiotics	on	intestinal	microbiota	has	been	
a focus on companion animal research. There are readily available commercial 
dietary	products,	where	a	specific	probiotic	and	prebiotic	(fiber)	are	added.	Feeding	
different diets with and/or without fructooligosaccharide (FoS) to dogs resulted 
in an inconsistent isolation of Bifidobacterium and Lactobacillus in canine faecal 
samples (Willard et al. 2000), whereas the Bifidobacterium levels in another study 
increased after feeding dogs a diet with a prebiotic oligofructose (Flickinger et al. 
2000). Further, dietary FoS, an indigestible carbohydrate source, decreased the 
faecal numbers of Clostridium perfringens in dogs in vivo (Swanson et al. 2002). In 
an	earlier	study	it	was	shown	that	moderately	fermentable	fiber	such	as	beet	pulp,	
pectin	could	have	beneficial	effects	in	dogs	as	these	sources	increase	the	colonic	
mucosal	area	and	colon	weights	compared	with	nonfermentable	dietary	fiber	such	
as cellulose (Reinhart et al. 1994). 
A recent canine pyrosequencing and metagenomic study compared the effects 
of	7.5%	beet	pulp	fiber	diet	with	a	0%	supplemental	fiber	diet	(control	group)	on	
faecal microbiota (Middelbos et al. 2010). That study found that the proportions 
of Actinobacteria and Fusobacteria were decreased compared with those of the 
control dogs, whereas Firmicutes notably Clostridia, which represented the largest 
proportion of sequences were increased. Similar results were obtained in cats fed 
on a diet with 4% FoS, which increased the faecal proportions of Actinobacteria 
compared with 4% cellulose or pectin treatments (Barry et al. 2012). In the same 
study, 4% pectin treatment increased the proportions of Firmicutes as compared 
with the other treatments. The most recent comprehensive pyrosequencing study 
in dogs fed raw meat-based diets with or without 1.4% inulin or yeast cell wall 
extracts (crude protein = 25 to 30%; fat = 45 to 50%, both on dry matter basis) 
detected no dietary changes at the phylum level (Beloshapka et al. 2013). In that 
same study, however, dogs fed the inulin-supplemented diets had decreased faecal 
Fusobacterium. These data indicate that the intestinal microbiota could be shifted 
due	to	the	inclusion	of	specific	fermentable	fibers.
2.2.3 dIetary proteIn and IntestInal mIcrobIota
The valuable substrates for intestinal bacteria and energy can also be derived from 
dietary proteins and the proteins of pancreatic enzymes after carbohydrate sources 
have been exhausted (Cummings & Macfarlane 1991; gibson et al. 1996; Nery et 
al. 2012). 
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Dietary proteins consist of amino acids: non-essential amino acids and essential 
amino acids. The former can be synthesized by the host and the latter can only 
be supplied by the diet. The fermentation of the protein and protein products 
such as amino acids mainly takes place in the distal part of the large intestine by 
intestinal proteolytic bacteria including Bacteroides, Fusobacterium, Clostridium, 
Streptococcus, Lactobacillus, and Propionibacterium, which produce SCFAs, along 
with BCFAs such as isobutyrate, 2-methylbutyrate, and isovalerate.  Undesirable 
metabolic end-substances such as phenols, amines, ammonia, sulphur, N-nitroso, 
indolic compounds, heterocyclic amides are also produced, but this depends on 
the amino acid content of the proteins (Macfarlane et al. 1986; Wong et al. 2006; 
Nyangale et al. 2012; Scott et al. 2012, Salonen & de Vos 2014). It is worth mentioning 
that proteins and amino acids provide much less energy to the host in the large 
intestine compared to the carbohydrates (Macfarlane et al. 1992).
The undesired metabolic end-products are of importance due to the potential 
toxic and carcinogenic properties for the colonocytes and for the host. For example, 
ammonia is believed to be involved in hepatic encephalopathy, the pathogenesis of 
colon cancer, colitis, and colonic hypersensitivity in rats and humans (Royall et al. 
1990; guilford 1997; Hughes et al. 2000; Bajka et al. 2008; Vipperla & o`Keefe 
2012). In addition, long feeding of high levels of casein (25% of total dietary protein) 
leads to genetic damage of colonocyte and possibly to symptoms suggestive of 
gastrointestinal disease such as colorectal cancer in rats, whereas high-amylase 
corn starch prevents the damage of colonocytes, which is probably mediated through 
butyrate production by large bowel bacterial fermentation (Bajka et al. 2008). 
Another study found that colonocyte DNA damage, measured by single-strand 
breaks, was more prevalent in rats fed diets that were higher in various dietary 
proteins, including casein, red meat, or a soy protein isolate (Toden et al. 2007b). 
Ammonia was negatively correlated with villus height in pigs (Nousiainen 1991) and 
it can also disturb the development of the mucosa of the large intestine in humans 
(Visek 1984). It is also known, that increased levels of dietary protein could make 
the colonic mucus layer thinner, this would indicate a loss of barrier function, which 
is characteristic of IBD (Toden et al. 2005, 2006). Various studies demonstrated 
increased faecal water content and/or high faecal ammonia concentrations, which 
was primarily associated with the qualitative and quantitative dietary protein source 
and to a lesser extent associated with the carbohydrate concentration of the diet 
(Zentek et al. 1995a; Dong et al. 1996; Meyer et al. 1999; Rolfe et al. 2002; Zentek 
et al. 2003; Muir et al. 2004; Wong et al. 2006; Jha & Leterme 2012; Nery et al. 
2012).	The	same	studies	also	showed	that	a	sufficient	throughput	of	carbohydrate	
leads to a decrease in luminal nitrogenous compounds.
It should be mentioned, that in addition to ammonia, phenolic and indolic 
compounds produced during the protein hydrolysis, sulphur compounds (i.e., 
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hydrogen sulphide, H2S) are also produced. These sulphur compounds are reduced 
by the reduction of sulphate from the protein source such as dietary protein, 
mucus, pancreatic secretions by sulphate-reducing bacteria Desulfomonas spp., 
Desulfovibrio	spp.	present	in	the	colon.	There	are	specific	amino	acids	i.e.,	cysteine	
and	their	derivates	(taurine),	which	also	contain	sulphur	and	is	produced	by	specific	
bacteria (E. coli, Clostridium spp.). This further adds to the pool of colonic H2S. 
Hydrogen sulphide has been associated with ulcerative colitis in humans due to 
its ability to reduce the barrier function of colonocytes, which possibly allows for 
the entrance of carcionogens and other unwanted protein metabolites (Pitcher & 
Cummings 1996; Hughes et al 2000; Blachier et al. 2009; Nyangale et al. 2012). 
Knowledge	about	the	influence	of	dietary	protein	on	canine	intestinal	microbiota	
is rather limited. Some research has addressed the effect of dietary protein on satiety 
of appetite, faecal consistency and also quantity of Clostridium perfringens in canine 
faeces (Zoran 2003; Zentek et al. 2004). Earlier studies that used bacterial cultures 
for the assessment of dietary effects on the microbiota, found that the number of 
CFUs of C. perfringens were increased in dogs fed animal protein of either poultry 
or beef (Zentek et al. 2004). The same was concluded in an earlier study in which 
the number of C. perfringens CFU was increased and that of Bifidobacterium were 
decreased in dogs fed large quantities of a low-quality protein diet (Zentek 1995a,b,c). 
A recent pyrosequencing study in kittens (8 to 16 weeks old), fed either a 
moderate-protein, moderate-carbohydrate diet (crude protein = 34%; fat = 20%, 
both on dry matter basis) or a high-protein, low-carbohydrate diet (crude protein 
= 52%; fat = 23%, both on dry matter basis), reported large faecal microbial shifts 
due to dietary treatments at the phylum, family, and genus levels. The kittens fed 
the high-protein low-carbohydrate diet had higher proportions of Firmicutes, 
Fusobacteria, and Proteobacteria in their faecal samples compared with those 
fed moderate-protein, moderate-carbohydrate diet (Hooda et al. 2013).
The characteristics of microbial fermentation are also affected by the physical 
form of the food, which depends on the manufacturing process of the diet 
(Macfarlane & Macfarlane 2003). Evidence for this was provided by a study that 
addressed the impact of food processing. In that study dogs that were fed canned 
food with poultry and/or beef as the protein source were found to have a lower total 
faecal SCFAs and higher levels of faecal valeric compared to dogs fed commercial 
dry food with poultry as the protein source (Zentek et al. 2004). 
Dietary fat was not studied in this research project as it is mostly degraded and 
absorbed in the small intestine, and hence would not reach the colon to impact 
upon the microbiota of the large intestine. Dietary fat could, however, exert an 
effect indirectly through bile acids, which are secreted in the small intestine by the 
host as a constituent of bile as part of the  digestion process of dietary fat. Therefore 
bile acids could inhibit microbial growth, if they were to reach the colon.  Various 
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intestinal microbes have genes, which encode bile salt hydrolases deconjugating 
the bile salts, which help overcome the possible negative impact of bile salts on 
intestinal microbiota (Jones et al. 2008; Zoetendal & de Vos 2014).
In conclusion, the host-microbe interactions are mutualistic as the host is, in turn, 
responsible for providing the essential nutrients for bacterial growth, metabolism 
and life (Savage 1977; Noverr & Huffnagle 2004; guarner 2006; Flint et al. 2007; 
Salonen & de Vos 2014; Zoetendal & de Vos 2014). 
2.2.4 calprotEcin – a markEr for intEstinal inflammation
Macronutrients	can	detrimentally	influence	intestinal	health	by	their	involvement	in	
inducing	intestinal	mucosal	inflammation.	There	are	various	methods	for	assessing	
colonic	 inflammation	in	humans:	the	histological	evaluation	of	colonic	biopsies;	
and the measurement of faecal biomarkers such as calprotectin, lactoferrin, or 
polymorphonuclear neutrophil elastase (Langhorst et al. 2008; Vieira et al. 2009). 
In	the	past	there	has	been	a	lack	of	species-specific	faecal	biomarkers	for	use	in	dogs.	
Therefore, endoscopic sampling of the intestinal mucosa under general anaesthesia 
was needed for collection of colonic biopsies (Sauter et al. 2006). 
Recently,	a	RIA	was	developed	and	analytically	validated	for	the	quantification	of	
canine calprotectin in serum and faeces, which allowed the noninvasive assessment 
of	possible	intestinal	inflammation	(Heilmann	et	al.	2008a,b).	Faecal	calprotectin	is	
a	sensitive	but	nonspecific	marker	for	intestinal	inflammation	that	binds	to	calcium	
(Ca2+) and zinc (Zn2+) (Melling et al. 1996; Tibble et al. 1999). In addition, it also 
has bacteriostatic and fungistatic properties (Miyasaki et al. 1993; Brandzaeg et 
al. 1995), and protects against infection and contributes to the innate immunity of 
the host. For example, bacteriostatic effects of calprotectin were found for Listeria 
monocytogenes, Salmonella enterica subsp. enterica serovar Typhimurium and E. 
coli (Nisapakultorn et al. 2001; Heilmann et al. 2008a). Calprotectin is expressed by 
various cells including: neutrophils, monocytes and activated macrophages (odink 
et al. 1987). However, small amounts of calprotectin were also found to be expressed 
by keratinocytes (Wilkinson et al. 1988). Furthermore, increased calprotectin levels 
in	serum	and	other	body	fluids	have	been	detected	in	humans	with	Crohn’s	disease,	
ulcerative colitis (Roseth et al. 1992; Lügering et al. 1995; Fagerhol 2000; Burns 
et al. 2001; Roseth et al. 2004), colorectal cancer (Roseth et al. 1993), rheumatoid 
arthritis,	and	cystic	fibrosis	(Berner	et	al.	1991;	Golden	et	al.	1996).	In	addition,	
the levels of calprotectin were elevated in human patients by non-steroidal anti-
inflammatory	drug	(NSAID)	treatment	(Roseth	et	al.	1993;	Tibble	et	al.	1999,	2000),	
and also in patients with psoriasis (Kunz et al. 1992). Elevated serum and faecal 
calprotectin concentrations have also been detected in dogs with IBD or with chronic 
Review of the literature
32
diarrhoea (Heilmann et al. 2012; grellet et al. 2013). Therefore, there is evidence for 
its	usefulness	as	a	marker	of	inflammation	and	also	for	the	contribution	it	makes	
to the maintenance of the host’s defence mechanism (Lusitani et al. 2003). 
2.3 molecular methods for analyzIng the IntestInal  
 mIcrobIota
Conventional bacterial culturing has been the mainstay method for investigating 
the canine gastrointestinal microbiota (Simpson et al. 2002; Mentula et al. 2005). 
However, it has been acknowledged that the actual cultures obtained represent only 
a small proportion of the bacterial diversity actually present in the gut (Zoetendal 
et al. 2008; Suchodolski 2011). Therefore high throughput DNA- or RNA-based 
molecular methods were developed in order to detect target bacteria in complex 
ecosystems of interest (Zoetendal et al. 2008). At the time of writing this thesis, 
seven bacterial groups (Bacteroides, Clostridium, Lactobacillus, Bifidobacterium, 
Fusobacterium, Enterobacteriaceae and Coriobacterium)	in	five	predominant	phyla	
(Firmicutes, Fusobacteria, Bacteroidetes, Proteobacteria and Actinobacteria) have 
been	identified	ín	samples	taken	from	the	canine	GIT	using	conventional	bacterial	
culturing and different molecular methods (greetham et al. 2002; Mentula et al. 
2005; Suchodolski et al. 2008a, 2011; Handl et al. 2011; Wakshlag et al. 2011; 
Beloshapka et al. 2013). 
2.3.1 bacterIal 16s rrna gene
The culture-independent methods are often based on detecting the bacterial 16S 
rRNA gene, which codes for the production of the 16S ribosomal ribonucleic acid. 
The 16S rRNA gene has many useful properties: it is functionally universal as it 
contains	several	conserved	regions,	it	is	sufficiently	conserved	and	it	also	has	a	useful	
size of approximately 1500 nucleotides. In addition, large sequence databases of 
the 16S rRNA exist that allow for comparing obtained sequences. The 16S rRNA 
gene also contains hypervariable regions, which are unique at various taxonomic 
hierarchy	levels	that	enable	the	taxonomic	positioning	and	identification	of	bacteria	
and archaea up to the species level. The 16S rRNA gene also contains conserved 
regions that have remained constant over the time, thus targeting those regions is 
favoured when one would like to analyze the entire complex bacterial community 
(olsen et al. 1986, Woese 1987). Currently, approximately 1.8 million of 16S rRNA 
gene sequences are available in public data banks (Ribosomal Database Project; 
http://rdp.cme.msu.edu/). The outline of these culture-independent methods is that 
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the bacterial cell is physically or chemically broken, the DNA or RNA is extracted 
and	the	16S	rRNA	gene	is	amplified	by	the	polymerase	chain	reaction	(PCR),	by	
using	universal	primers,	group	primers,	or	species-specific	primers	(Zoetendal	et	
al. 2004, 2008). 
The gIT microbiota analysis is subject to various biases, including sampling 
protocol, handling and storage of the samples, bacterial cell lysis and DNA extraction; 
selection of primers, formation of chimeras during the polymerase chain reaction 
(PCR), or the analysis method used (von Wintzingerode et al. 1997; Zoetendal et 
al. 2004; Salonen et al. 2010). 
2.3.2 profIlIng based on guanIne + cytosIne composItIon 
Profiling	based	on	the	nucleotide	composition	of	DNA	is	non-quantitative	and	
suitable for investigation of previously unknown bacterial populations. This method 
has many advantages over the other DNA-based methods: it is independent of 
any	previous	information	about	the	bacteria	of	interest;	PCR	amplification	is	not	
required so there is less likelihood for artefacts to occur with an increasing number 
of PCR cycles or with choosing incorrect primers and probes (Holben & Harris 
1995;	Hart	et	al.	2002;	Suchodolski	et	al.	2005).	The	G+C	method	relies	on	the	
fractionation of bacterial chromosomal DNA by density gradient centrifugation that 
is based on their guanine-cytosine (g-C) content (Holben et al. 2004).  Each bacterial 
chromosomal DNA has a characteristic g-C content that is expressed as a percentage, 
which is directly associated with the density of the DNA. For example, g-C rich 
DNA is denser than the adenine-thymine, A-T, rich DNA. Moreover, migration by 
density	gradient	centrifugation	occurs	when	DNA	with	high	%G+C	content	migrates	
differently	compared	to	DNA	with	low	%G+C	and	the	characteristic	absorbance	
by ultraviolet (UV) are properties that make it  possible to gather the information 
about the microorganisms of interest that include bacteria, archaea and fungi. In 
other	words,	it	is	a	profiling	approach	and	does	not	give	exact	bacterial	names,	but	
does give taxonomically relevant information about the bacteria of interest, which 
facilitates subsequent analysis. Fractionating the bacterial DNA according to the 
%G+C	content	allows	the	less	abundant	bacteria	to	be	amplified	by	universal	PCR	
prior to cloning and sequencing (Apajalahti et al. 2001; Holben et al. 2004). This 
is especially important for detecting the bacteria with high g-C content as was 
shown	in	a	study	by	Krogius-Kurikka	et	al.	(2009),	which	reported	that	the	%G+C	
profiling	approach	did	increase	the	sequence	diversity	for	the	bacteria	with	high	
g-C content in human faecal samples. 
Review of the literature
34
2.3.3 sanger sequencIng of 16s rrna gene
After	the	%G+C	profiling,	the	bacterial	DNA	fractions	obtained	are	subjected	to	
subsequent	16S	rDNA	gene	PCR	amplification	with	a	universal	broad-range	primers	
that are targeted at the conserved regions of the 16S rRNA gene. Agarose gels are 
used	in	conventional	PCRs	in	order	to	detect	the	correct	size	of	PCR	amplification	
products at the end-point of the PCR reaction. The end-point PCR is not a convenient 
method for quantitative analyses because during the reaction some reactants usually 
become limited and therefore it is not possible to measure accurately the quantity of 
the	initial	bacterial	material	in	the	sample	of	interest	(Mullis	1990).	The	amplified	
PCR products are further analyzed by constructing the clone libraries and sequencing 
the appropriate number of individual clones in order to determine the microbial 
diversity in a sample of interest (olsen et al. 1986). Cloning and sequencing of the 
bacterial 16S rRNA gene provides valuable information about the microbiota of the 
gIT. The Sanger sequencing approach used in this study applies di-deoxy analogues 
of deoxynucleoside triphosphates, which terminate polymarization at a known base 
(Sanger	et	al.	1977).	The	newly	isolated	sequences	can	be	quite	precisely	identified	
by comparing their 16S rRNA gene sequences against previously analyzed sequences 
listed in the public databases. The most comprehensive 16S rRNA gene cloning and 
sequencing study has been done in humans, where more than 13 000 16S rRNA 
gene	sequences	were	determined	in	faecal	samples	(Eckburg	et	al.	2005).	The	%G+C	
profiling	approach	with	subsequent	cloning	and	sequencing	has	been	successfully	
applied to study bacterial communities in various environments, such as soils, or 
the gI tracts of humans or different animals (Apajalahti et al. 2001; Apajalahti et 
al. 2002; Holben et al. 2004; Kassinen et al. 2007; Krogius-Kurikka et al. 2009). 
The innovation of pyrosequencing (Margulies et al. 2005) has made high-
throughput analysis possible in canine research, especially where it has been used 
in detecting the species richness and diversity in canine skin allergies (Rodrigues et 
al. 2014), intestinal diseases (Suchodolski et al. 2012) and obesity (Handl et al. 2013). 
In addition, it has also been applied in studies that address dietary trials (Beloshapka 
et al. 2013) and in the characterisation of the fungal microbiome in canine faecal 
samples (Foster et al. 2013). The results of different canine metagenomic studies 
have been discussed in chapter two section one of this thesis. Moreover, other 
next-generation sequencing methods have been developed to capitalize on newly 
developed instruments, such as Illumina MiSeq and HiSeq (Caporaso 2012). Further 
metagenomic approaches in canine research are expected to widen the view of 
community structure namely: species richness and distribution, for analysing fungi, 
archaeal and viral genomes. other approaches involve using functional (metabolic) 
potentials in order to enhance our understanding of host–microbe relationships, 
with applications to host metabolism and disease.
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aims of thE study
The aim of this PhD research was to investigate the effects of high-protein and 
high-carbohydrate	diets	on	canine	faecal	microbiota.	The	investigation	specifically	
covered the metabolic products of the microbiota, the reaction of the host to intestinal 
inflammatory	states	and	the	adaptive	changes	of	 the	pancreatic	enzyme	profile	
of microbiota. These aims were achieved by using several advanced laboratory 
methods such as molecular techniques to analyse intestinal microbiota, high 
performance	liquid	chromatography	(HPLC)	for	assessing	faecal	fatty	acid	profiles	
and	species-specific	RIAs	to	determine	canine	calprotectin	and	pancreatic	enzyme	
concentrations.
The following objectives were set:
 1.  to investigate the alterations in the intestinal microbiota of   
  Beagle dogs fed  diets of  high protein or carbohydrate content 
 2.  to study whether the effects of dietary greaves-meal and maize  
  starch on faecal microbiota can be associated with altered faecal  
	 	 characteristics,	SCFAs	profiles,	and	canine	faecal	calprotectin	levels
	 3.		 to	analyze	and	validate	RIAs	for	the	quantification	of	cTLI	and		
	 	 cPLI	in	jejunal	fluid	and	faecal	specimens	of	healthy	Beagle	dogs	
 4.  to investigate the dietary adaptive changes of the pancreatic  
	 	 enzyme	profiles	in	healthy	Beagle	dogs	that	possibly	influence		
  changes in the nutritional components in the intestinal contents  
  that are subsequently available for the fermentation by the   
  intestinal microbiota 
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3 matErials and mEthods
3.1 anImals and study desIgn 
Five laboratory Beagle dogs (origin: Harlan-Winkelmann, Borchen, germany; age: 
5 y; body weight: 18–22 kg; sex: male), were allocated to this study. Each dog 
had	a	permanent	jejunal	fistula	inserted	60	cm	distally	from	the	pylorus,	which	
had originally been prepared for an earlier unrelated study by Harmoinen et al. 
(2001).  All dogs were kept separately under identical conditions i.e. each dog was 
individually kept indoors, regularly vaccinated and dewormed as part of a colony 
according to European Union guidelines for indoor-pens (dimension 3.3-6.9 m2) 
at the Experimental Animal Unit of Helsinki University, Finland. The dogs were 
exposed	to	artificial	light	from	7-16	hours.	The	environmental	temperature	indoors	
was maintained within a range of 15-24°C. The Beagles were considered to be large-
framed but not obese as determined by visual inspection. good health was assumed 
based on the following factors: defecation history i.e. no history of diarrhoea for at 
least four weeks prior to selection, unremarkable physical examination, and normal 
results of standard laboratory test in blood including normal haematology, clinical 
chemistry and absence of faecal parasites.
 The study was designed as an incomplete graeco-Latin square, in which the 
following six trial phases were included: baseline phase with a dry commercial diet 
(DC diet: Mastery Pro Adult Dog Maintenance, Raili Pispa oy, Muurla, Finland; 
crude protein: 264 g/kg, starch: 277 g/kg); 14 d diet phases with high-protein 
greaves-meal diet (HPgM;  crude protein: 609 g/kg, starch: 54 g/kg) or with high-
carbohydrate starch diet (HCS; crude protein: 194 g/kg, starch: 438 g/kg) or with 
the DC diet, 21 d each. Subsequently 28 d washout phases (Wo) of feeding the DC 
diet followed after the HPgM diet phase and after the HCS diet phase. All phases 
were crossed-over according to the graeco-Latin square schedule shown in Table 3. 
Each treatment period counted sequentially from d 1 at the beginning of the study 
baseline as the study progressed to d 129 when the study treatments and sampling 
ended. An example of the the sampling time points in the feeding sequence is given 
for dog two (Table 3) whereby d 10-12 was the end of feeding the baseline DC diet, 
d	29-31	was	the	end	of	feeding	the	HPGM	diet,	d	57-59	was	the	end	of	first	washout	
period with the DC diet, d 78-80 was the end of HCS diet, d 106-108 was the end 
of second washout period with the DC diet, and d 127-129 was the end of DC diet 
period. The feeding sequence is shown in Table 3.
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table 3. The feeding sequence of the HPGM, HCS, and DC diets over six feeding periods (I-IV).
dog baseline  
(dc)
diet (dc, hpgm, and hcs) and washout periods 
(wo)
1 DC diet DC1 HPGM2 WO3 HCS4 WO
2 DC diet HPGM WO HCS WO DC
3 DC diet HC WO DC HPGM WO
4 DC diet DC HCS WO HPGM WO 
5 DC diet HCS WO HPGM WO DC
  
1 DC: dry commercial (DC) diet
2 HPGM: high-protein greaves-meal diet
3 WO: washout period with the DC diet
4 HCS: high-carbohydrate starch based diet
3.2 dIets 
The HPgM and HCS diets were formulated at the Institute of Animal Nutrition (Freie 
Universität Berlin, Berlin, germany) to obtain considerable differences between 
them for protein and starch, and their nutrient contents to previously developed 
standard methods for feed analyses (Naumann & Bassler 1983). The HPgM and 
HCS	diets	were	composed	of	greaves	meal,	corn	flakes,	sunflower	oil,	minerals	and	
vitamins. greaves meal is the residue water melting out the fat from pork or cattle 
tissue. Ingredients and analysis of crude nutrients are shown in Tables 4 and 5.
table 4. Composition in per cent of the HPGM, HCS and DC diets fed to five dogs in a Graeco-Latin 
square design (I-IV).
ingredient hpgm diet % hcs diet % dc diet %
Greaves meal 80 17 0
Dehydrated meat 0 0 27
Corn flakes (heat-treated) 15 72 0
Maize (cooked) 0 0 65
Sunflower oil 2 8 0
Vegetable oils 0 0 3
Minerals and vitamins 3 3 5
Total 100 100 100
Materials and methods
38
table 5. Nutrient analysis and trace element contents of the HPGM, HCS and DC diets fed to dogs in a 
Graeco-Latin square design (I-IV).
nutrient
g/kg
hp diet hc diet dc diet
Dry matter 930.4 906.9 913.9
Crude ash 49.0 39.4 85.4
Crude protein 609.1 193.7 263.5
Crude fat 150.4 132.7 99.7
Crude fibre 73.8 59.0 103.8
Starch 54.4 438.4 277.0
mineral g/kg
Calcium 6.6 6.2 16.4
Sodium 7.0 4.8 6.0
Magnesium 1.5 1.3 1.3
Potassium 5.2 2.2 5.8
Phosphorus 6.2 4.4 12.7
trace element mg/kg
Copper 23.4 19.2 21.6
Iron 252.1 196.3 365.2
Zinc 135.2 108.1 205.1
Manganese 101.0 277.1 111.3
Dogs were weighed once a week in the morning, before feeding. The amount of food 
allocated to each dog during the study was calculated according to the individual 
energy requirements for each dog before entering the study. The metabolic energy 
content was 1.54 MJ/100 g of the HPgM diet, 1.49 MJ/100 g of the HCS diet 
and 1.25 MJ/100 g of the DC diet. The diets were given to meet the daily energy 
requirements estimated at 0.5 MJ metabolisable energy/kg0.75. Food weighing after 
feeding was not needed as all the dogs ate all of their respective meals at every 
feeding point. Water was provided freely during the entire study.
3.3 ethIcs
The experimental protocols were approved by the local Ethics Committee for Animal 
Use and Care in Helsinki, Finland (license ESLH-2008-04002/Ym-23).
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3.4 sample collectIon and handlIng
Serum,	jejunal	fluid	and	faecal	samples	were	collected	for	Study	IV.	Jejunal	fluid	
and faecal samples were collected for Study III. Faecal samples were collected for 
Studies I and II.
3.4.1 serum samples (IV)
Approximately 2 mL of blood samples (n=20 total) were drawn from the cephalic 
vein once at the end of each dietary phase on day 18. The serum was separated 
from the coagulated blood component by decanting, and the serum samples were 
frozen at -80oC until they were packed on dry ice and sent to the gastrointestinal 
Laboratory, Department of Small Animal Clinical Sciences, Texas A&M University, 
College Station, Texas, USA, where they were thawed immediately prior to the 
determinations of cTLI and cPLI. 
3.4.2 JEJunal fluid samplEs (III, IV)
Approximately	0.5	mL	jejunal	fluid	aliquots	(n=5	for	Study	III	and	n=120	for	Study	
IV)	were	taken	via	the	permanent	jejunal	nipple	valve	fistulas	(approximately	60	
cm distal to the pylorus) at 2 h after the morning feeding as described previously 
by Harmoinen et al. (2001). These samples were taken on the last three consecutive 
days	of	every	dietary	treatment	for	every	dog.	Briefly,	jejunal	samples	were	obtained	
by inserting a silicon tube through the nipple valve into the jejunum, while the dog 
was standing. The containers with the jejunal samples were immediately placed into 
an	ice	bath	at	-2°C	after	collection.	Jejunal	fluid	aliquots	were	either	kept	frozen	at	
-20°C	for	further	analyses	of	amylase	activity	or	frozen	first	at	-80°C,	then	packed	
on dry ice and sent to the gastrointestinal Laboratory, Department of Small Animal 
Clinical Sciences, Texas A&M University, College Station, Texas, USA for analyses 
of cTLI, cPLI, and cE1 concentrations.
3.4.3 faEcal samplEs (I-IV)
Faecal samples (n=410 total) were obtained after the morning feeding. out of 410 
faecal samples, 300 samples were collected for Study II, 45 samples for Study I, 
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5 samples for Study III and 60 samples for Study IV. Fresh naturally-passed 1-g 
faecal samples were collected immediately after defecation on three consecutive 
days at the end of each dietary phase. The bottom layers of the stools were left 
untouched	on	the	floor	to	ensure	the	samples	contained	only	faecal	material	(I-
IV). Faecal samples in their containers were immediately placed into an ice bath 
at -2°C after collection.
Several fresh 1 g quantities of faecal specimens (n=60 total) were thoroughly 
homogenized and faecal pH was measured immediately after collection (II). Several 
1-g quantities (n=120 total) were also pretreated in polypropylene tubes before 
freezing at -20oC for further analyses of ammonia and volatile fatty acids (VFAs) 
Study (II). one gram aliquots (n=60 total) were immediately placed in preweighed 
sterile Sarstedt faecal collection tubes (101×16.5 mm; incl. spatula; Sarstedt oy, 
Vantaa, Finland) and frozen at -20oC for dry matter determinations.
A subsample (n=120) in preweighed sterile Sarstedt faecal collection tubes 
(101×16.5 mm; incl. spatula; Sarstedt oy, Vantaa, Finland) was frozen either at -80oC 
or -20oC, packed on dry ice and sent to the gastrointestinal Laboratory, Department 
of Small Animal Clinical Sciences, Texas A&M University, College Station, Texas, 
USA for the measurement of faecal canine calprotectin (II) and cTLI, cPLI, and 
cE1 concentrations in faecal extracts (III, IV), respectively.
other 1-g quantities (n=45 total) of faeces were immediately placed in pre-
weighed sterile Sarstedt faecal collection tubes using a spatula (Sarstedt oy, Vantaa, 
Finland) and frozen at -80oC, packed on dry ice and sent to Alimterics laboratory, 
Alimetrics Ltd, Finland for the further analysis of canine faecal microbiota (I). 
3.5 clInIcal parameters (I-IV)
Body weight, food intake, and faecal consistency scores were determined daily, 
as	described	previously	by	Kilpinen	et	al.	2011.	Briefly,	a	score	of	1	was	given	for	
very dry and hard faecal stool. Stools that could be picked up easily but were not 
dry and hard were given a score of 2. A score of 3 was given for well-formed and 
slightly moist faecal stool. Poorly formed and very moist faeces that resembled the 
consistency of porridge were scored as 4. Unformed and watery faeces were given 
a score of 5. Faeces with a consistency between two adjacent scores had a 0.5 score 
added to the lower value and thus were recorded as 1.5, 2.5, 3.5, or 4.5. Dogs were 
weighed once a week in the morning, before feeding. The amount of food given in 
grams was weighed before it was given to each dog. Food weighing after feeding was 
not needed as all the dogs ate all of their respective meals at every feeding point.
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3.6 mIcrobIology studIes (I)
After delivery to the Alimetrics laboratory the three faecal samples taken on three 
consecutive days from each dog were thawed and subsequently pooled prior to the DNA 
extraction. Therefore, the number of samples subjected to DNA extractions was 15.
3.6.1 bacterIal dna extractIon from faecal samples 
Bacterial DNA extraction was carried out essentially as described by Apajalahti et 
al.	(1998).	Briefly,	bacteria	in	the	samples	were	initially	washed	and	separated	by	
repeated differential centrifugation to remove the solid particles and inhibitory 
factors such as complex polysaccharides. Subsequently, bacterial cell walls 
were	disrupted	using	both	enzymatic	and	mechanical	 lysis	steps	and	finally	the	
chromosomal	DNA	was	quantitatively	purified	by	gravity-flow	anion	exchange	tips.
3.6.2 total communIty analysIs by %g+c profIlIng
The faecal microbial DNA of each dietary group was pooled i.e. samples from all 
five	dogs	for	each	of	the	three	dietary	treatments	(DC,	HCS,	and	HPGM	diets).	The	
pooled DNA samples were concentrated by precipitation using isopropanol a sthe 
precipitation	agent	and	then	dissolved	in	400	μl	of	Tris-Ethylenediamineteraacetic	
acid (TE) buffer after which the DNA concentration was determined by a UV-
spectrophotometer	prior	to	the	profiling	of	the	percentages	of	guanine	and	cytosine	
(%G+C)	in	the	samples.
In	%G+C	profiling	each	of	the	three	pooled	DNA	samples was fractionated by 72 h 
CsCl equilibrium density gradient ultracentrifugation (100 000 × g), which separates 
chromosomes	with	different	G+C	contents	into	different	fractions.	This	separation	
is based on differential density imposed by the A-T-dependent DNA-binding dye 
bis-benzimidazole (Holben & Harris 1995). In the following ultracentrifugation the 
formed	gradients	were	pumped	through	a	flow-through	UV	absorbance	detector,	
which	was	set	at	280	nm	and	the	%G+C	fractions	were	collected	at	every	5%	intervals.
Three DNA fractions (referred herein to as Fractions 5, 10 and 14, respectively) 
from each sample were subjected to desalting in PD-10 columns (gE Healthcare 
Life Sciences, Little Chalfont, Buckinghamshire, UK) for subsequent 16 S ribosomal 
deoxyribonucleic	acid	(16S	rDNA)	gene	PCR	amplification	using	a	universal	broad-
range primer pair. 
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3.6.3 amplIfIcatIon of the 16s rrna genes and sequencIng
The nearly complete 16S rRNA gene fragments from each of the three desalted 
DNA	fractions	were	amplified	by	end-point	PCR	using	a	universal	primer	pair	that	
corresponded to the E. coli 16S rRNA gene positions 8–27 and 1389–1405, with 
sequences	5’-AGAGTYYGATCCTGGCTCAG-3’	(slightly	modified	from	Edwards	et	al.	
1989) and 5’-TgACgggCggTgTgTAC-3’ (Lane 1991). The oligonucleotide primers 
were synthesized commercially by MWg-Biotech Ag, Ebersberg, germany. The 50 
μl	PCR	reactions	contained	1	×	DyNAzyme™	Buffer	(Finnzymes,	Espoo,	Finland),	
0.2	mM	of	each	dNTP,	20	pmol	of	primers,	1	U	of	DyNAzyme™	II	DNA	Polymerase	
(Finnzymes, Espoo, Finland), 0.125 U of Pfu DNA polymerase (Fermentas, Vilnius, 
Lithuania)	and	10	μl	of	desalted	fractioned	DNA	template	(1:10	dilution	from	the	
desalted	stock	solution).	The	PCR	amplification	was	carried	out	by	30	cycles	for	each	
fraction.	After	PCR	reaction	the	correct	size	of	amplification	products	was	verified	
on	ethidium	bromide	stained	agarose	gel.	Finally,	the	PCR	products	were	purified	by	
the	QIAquick	PCR	Purification	Kit	(Qiagen,	Hilden,	Germany)	and	sent	to	cloning	
and sequencing to Agowa genomics, Berlin, germany. The following numbers of 
sequences	were	obtained	from	the	%G+C	fractions	from	each	diet:		
• Fraction 5 = 96 sequences per sample
• Fraction 10 = 96 sequences per sample
• Fraction 14 = 48 sequences per sample
Hence, the total number of sequences in this study was 720 (240 sequences per 
diet) on both strands.
3.7 methods for analyzIng bacterIa-derIVed   
 metabolIc products and calprotectIn (II).
3.7.1 faEcal dry mattEr
Faecal dry matter was determined by overnight oven-drying of each sample at 
103oC,	as	previously	described	by	Zentek	et	al.	2004.	Briefly,	1	g	of	thawed	faeces	
was placed into a washed and oven dried Petrie dish. Samples were oven dried 
at 103oC	for	18	h	(Heraeus,	Thermo	Fisher	Scientific	Inc.,	Waltham,	MA,	USA).	
Thereafter, subsamples were weighed on a Mettler AE 160 scale (Mettler-Toledo 
International Inc., Columbus, oH, USA) to the nearest of 0.0001 g. This protocol 
was used twice for each sample (n=60 total), therefore the means of two replicate 
measurements were calculated and entered into the data analysis.
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3.7.2 faecal ph
Faecal pH was measured by using a digital pH-meter (Knick pH-Meter 761 Calimatic, 
Knick Elektronische Messgeräte gmbH & Co, Kg, Berlin, germany), as previously 
described (Zentek et al. 2002, 2004). A 1-g faecal sample was placed into a 15-
ml Falcon tube, diluted with the distilled water (MilliQ) 1:9, vortexed at room 
temperature for three minutes, centrifuged at 5000 rpm at 25 oC for 15 min, followed 
by removing the supernatant to the new 15-ml Falcon tube and then measuring 
the pH with a digital pH-meter.The means of three replicate measurements were 
calculated and entered into the data analysis in order to ensure accuracy. The total 
number of faecal samples for measuring faecal pH in the current study was 60.
3.7.3 faecal ammonIa 
Ammonia was measured when 1-g faecal samples were pretreated by thorough 
mixing with 3 mL of 1 mol/L HClo4 before freezing at -20
oC. Thereafter pretreated 
samples (n=60 total) were thawed at room temperature. Faecal ammonia 
concentrations were measured by an enzymatic method (Bergmeyer & Beutler 
1990), using an ammonia assay kit (Ammonia Assay Kit, Megazyme International 
Ireland Ltd., Wicklow, Ireland) that was adapted for an automated chemistry 
analyzer (KONE	Pro,	Thermo	Fisher	Scientific,	Vantaa,	Finland),	according	to	the	
latter manufacturer´s instructions. 
3.7.4 faecal Vfa profIles 
The	 faecal	VFA	profiles,	 covered	values	 for	propionic	acid,	 acetic	 acid,	butyric	
acid, valeric acid, and BCFAs namely: isobutyric and isovaleric acid that had been 
determined	using	a	modified	version	of	previously	described	protocols	(Tangerman	
& Nagengast 1996; Zentek et al. 2004). This analytical protocol was as follows: 
0.5 g of fresh faeces were mixed with 4.25 mL of deionized water (MilliQ-water) 
and 250 µL of a premade solution of an internal standard (Internal standard: 140 
mM 4-methylvaleric acid in formic acid, Helsinki, Finland), the mixture was then 
vortex mixed for 4 min, centrifuged at 5000 x g	at	+4˚C	for	15	min,	which	was	
then followed by a further centrifugation of 1 mL of the supernatant at 10 000 x 
g	at	+4˚C	for	10	min.	The	clear	supernatant	was	then	filtered	into	a	1.5-mL	crimp	
vial	by	using	a	syringe	filter	(Acrodisc	LC	13	mm	with	a	0.2-µm	polyvinylidene	
fluoride	(PVDF)	membrane,	4450T,	Pall	Corporation,	Port	Washington,	New	York,	
USA) and stored at -20oC for further analysis of VFAs. VFA concentrations were 
determined when the 1.5-mL supernatant was thawed at room temperature and 1 
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µL	of	the	filtrate	was	used	for	gas	chromatography	with	a	flame	ionization	detector	
(Agilent 7890A and 7683, Agilent Technologies, Espoo, Finland). The total faecal 
sample	number	for	detecting	the	VFA	profile	was	60.
3.7.5 calprotectIn
Faecal calprotectin concentrations were determined at the gastrointestinal 
Laboratory at Texas A&M University. The faecal samples (n=60 total) for all dogs 
(n=5) for calprotectin determinations were collected on the last three consecutive 
days at the end of each dietary period then pooled for each dog for the respective 
treatment period (n=20 pooled samples for analyses). A previously developed and 
analytically validated in-house RIA was used (Heilmann et al. 2008b).
3.8 dIgestIVe enzymes (III, IV)
3.8.1 amylase assay
Frozen	jejunal	fluid	samples	(n=60	total)	were	thawed	on	ice,	centrifuged	at	18	000	x	
g	and	+4oC for 6 min prior to being assayed for amylase activity. The amylase activity 
in	 jejunal	fluid	was	measured	by	a	method	recommended	by	the	International	
Federation of Clinical Chemistry and Laboratory Medicine (IFCC) using the bespoke 
amylase assay kit that is used for the Konelab 30i automated chemistry analyzer 
(Konelab,	Thermo	Fisher	Scientific,	Vantaa,	Finland)	as	described	by	Lorentz	(1998).	
The means of three replicate measurements of amylase activity were calculated and 
used to ensure accuracy for data analysis.
3.8.2 elastase-1 assay
Both	jejunal	fluid	(n=60	total)	and	faecal	specimens	(n=60	total)	were	extracted	
using the extraction kit E1, which is part of a commercially available canine faecal 
elastase-1 assay (Extraction kit E1 Quick-Prep, Canine Faecal Elastase-1 (cE1) assay, 
ScheBoBiotech). Faecal specimens were extracted according to the manufacturer’s 
instructions.	 A	modified	 protocol	 was	 used	 for	 the	 extraction	 of	 jejunal	 fluid	
specimens,	with	1	μL	jejunal	fluid	being	placed	into	the	sample	cone	that	contained	
the extraction buffer and collection of the extract after 5 mins of incubation. The 
extraction kit E1 was used to ensure that cE1, canine trypsin-like immunoreactivity 
(cTLI), and canine pancreatic lipase immunoreactivity (cPLI) concentrations could 
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all be measured in one extracted specimen. The means of three measurements of 
jejunal	fluid	and	faecal	parameters	per	dietary	treatment	period	per	dog	per	day	
(n=3 for each dietary treatment period) were calculated and entered into the data 
analysis in order to ensure accuracy. 
3.8.3 radIoImmunoassay procedures for detectIng ctlI and cplI  
 concentratIons
Serum	samples	of	all	five	dogs	 (n=20	 total)	 for	cTLI	and	cPLI	determinations	
were collected on day-18 towards the end of each dietary period. A commercially 
available	RIA	(reference	 interval:	5.7-45.2	μg/L,	http://vetmed.tamu.edu/gilab/
service/assays/tli) and a specific pancreatic lipase immunoassay (reference 
interval:	0-200	μg/L,	http://vetmed.tamu.edu/gilab/service/assays/pli)	was	used	
for the measurement of cTLI and cPLI (gastrointestinal Laboratory, Texas A&M 
University).
RIA analysis was validated for cTLI and cPLI in Study III, by a commercially 
available competitive double antibody 125I-RIA kit (125I-RIA kit, PIKTLD-5, Siemens 
Medical Solution Diagnostics, CA, USA) that had been labeled for use in canine 
serum samples, which was used to measure cTLI concentrations in canine jejunal 
fluid	(n=5	total)	and	faecal	extracts	(n=5	total).	Both	jejunal	fluid	and	faecal	extracts	
were diluted 1:8 in assay buffer (0.05 M sodium phosphate, 0.02% W/V sodium 
azide, 0.5% W/V bovine serum albumin; pH 7.5). Assays were analyzed using an 
automated gamma counter (Automated gamma counter, Wallac 1470 Wizard, 
PerkinElmer) and corresponding software (Software, automated gamma counter, 
MultiCalc, Perkin Elmer) by comparison with serially diluted canine trypsin (1.0-
50.0	μg/L).	The	data	were	log/logit	transformed	to	generate	a	standard	curve	with	
concentrations of cTLI marked on the x-axis in a logarithmic fashion. Values on 
the y-axis were calculated from Y = loge([Bstandard/Bzero]/[1-(Bstandard/Bzero]) with Bstandard 
being the counts per minute (CPM) for each standard and Bzero being the CPM for 
the blank.
A previously developed 125I-RIA was used for the measurement of cPLI (Steiner 
and	Williams,	2003).	Both	jejunal	fluid	and	faecal	extracts	were	assayed	in	a	1:2	
dilution in the assay buffer, and were analyzed by comparison to serially diluted 
cPLI	standards	(6.25-400	μg/L).	A	smoothed	spline	 function	was	used	 for	 the	
standard curve. Concentrations of cPLI were recorded on a logarithmic scale on the 
x-axis, and values on the y-axis were calculated from Y = (Bstandard/Bzero) x 100. The 
means	of	two	measurements	of	jejunal	fluid	and	the	means	of	three	measurements	
of faecal parameters per dietary treatment period per dog per day (n=3 for each 
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dietary treatment period) were calculated and entered into the data analysis in 
order to ensure accuracy. 
The analytically validated radioimmunoassay used in Study III was also used 
to	measure	the	cPLI	and	cTLI	concentrations	in	jejunal	fluid	samples	(n=60)	and	
in faecal samples (n=60) in Study IV.
3.9 data handlIng and statIstIcal analyses
Study I	The	%G+C	content	that	represented	each	gradient	fraction	in	the	faeces	
was determined by linear regression analysis (r2>0.99). The data were obtained 
from the control gradients that contained bacterial standard DNA samples for 
which	the	%G+C	composition	had	already	been	determined	in	this	case	Clostridium 
perfringens, Escherichia coli.	Two	sample	t-tests	were	used	to	detect	significant	
differences	between	the	%G+C	profiles	between	the	different	treatment	groups.
In the analysis of 16S rDNA sequences, the bi-directional contigs were checked for 
orientation and sequence quality and only those with the correct primer sequences 
and one-way read length above 900 bp were accepted for further analyses. Potential 
chimeras were revealed using the Ribosomal Database Project II Chimera Check. The 
PCR primer and cloning vector sequences were removed and 16S rDNA fragments 
were compared to a public 16S Ribosomal Database Project II (RDP-II) to determine 
the closest match to the aligned sequences of a known species. If the Sab score 
(similarity score a versus b) of a cloned sequence was > 0.95 to the type strain of 
any known species, the cloned sequence was assigned to that particular species 
(Cole et al. 2009).
The microbial community comparison based on 16S rRNA sequences was 
performed using Library Compare tool of RDP II. This tool uses the RDP naïve 
Bayesian	 classifier	 to	provide	 rapid	 classification	of	 library	 sequences	 into	 the	
new phylogenetically consistent higher-order bacterial taxonomy. It estimates the 
probability of observing the difference in a given taxon for the two libraries using 
a statistical test (Cole et al. 2009).
Study II and IV Data are presented as medians and ranges, and were analyzed 
by Excel and JMP 7.0. The data of samples taken on the last three consecutive days 
at the end of each diet period were assessed for all parameters analysed, except faecal 
calprotectin and serum digestive enzyme (i.e., cPLI and cTLI) concentrations. The 
means of parameters of food intake, body weight, and faecal consistency score, faecal 
dry	matter,	pH,	ammonia,	VFA,	faecal	and	jejunal	fluid	digestive	enzymes	over	three	
consecutive days for each dog were calculated and each parameter was entered as 
a single datum and to analyze the differences among the three different diets. The 
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faecal calprotectin concentrations represent one pooled sample of three consecutive 
days (one faecal sample per day) at the end of each diet period. The serum cPLI and 
cTLI concentrations represent a sample taken at the end of each dietary treatment 
period.	The	significance	of	the	dietary	effect	was	determined,	using	a	mixed-effect	
model that included the following parameters: dog, dog x diet interaction, and 
the time nested under the diet as random effects. The ANoVA test was used for 
continuous data or a non-parametric Kruskal-Wallis test was used to analyze non-
prametric data for evaluating the differences among the diet treatments. Pair-wise 
Spearman	correlation	coefficients	were	calculated	for	all	parameters	measured.	
Unless otherwise stated, the p-values reported refer to the mixed-effect model (II) 
or	to	the	Kruskal-Wallis	tests	(IV).	A	test	level	of	α	=	0.05	was	used	as	the	cut-off	
point	below	which	statistical	significance	was	attained.
Study III The analytical validation of the cTLI- and cPLI RIA data were achieved 
by the determination of the lower detection limit, linearity, accuracy, repeatability 
and reproducibility. The lower detection limit (analytical sensitivity) for the cTLI-
RIA	is	given	by	the	manufacturer	as	0.44	μg/L.	The	lower	detection	limit	of	the	
cPLI-RIA was determined by calculating the mean and standard deviation (SD) of 
Bzero tested 11 times in duplicates within the same assay run (Valentin et al. 2011). 
Linearity of the cTLI-RIA was evaluated by calculating the observed-to-expected 
(O/E)	ratios	for	five	different	jejunal	fluid	extracts	serially	diluted	1:8-1:64,	for	three	
faecal extracts diluted 1:2-1:16 and for two faecal extracts diluted 1:4-1:32. Linearity 
of	the	cPLI-RIA	was	assessed	for	two	different	jejunal	fluid	extracts	at	serial	dilutions	
from	1:1-1:8,	for	three	different	jejunal	fluid	extracts	diluted	1:2-1:16	and	for	five	
different faecal extract diluted 1:1-1:8. Accuracy of the cTLI-RIA was determined 
by calculating o/E ratios for the recovery of six different spiking concentrations of 
inactivated	canine	trypsin	(1.0,	2.0,	5.0,	10.0,	20.0,	and	50.0	μg/L;	equivalent	to	
assay	standards)	in	five	different	jejunal	fluid	and	faecal	extracts.	Spiking	recovery	
was evaluated for six different spiking concentrations of cPLI (6.3, 12.5, 25.0, 50.0, 
100.0,	and	200.0	μg/L;	equivalent	to	assay	standards)	in	five	different	jejunal	fluid	
and faecal extracts. 
Repeatability of both the cTLI- and cPLI-RIA was determined by calculating intra-
assay	coefficients	of	variation	(CV)	for	five	different	jejunal	fluid	and	faecal	extracts	
each of which was assayed 10 times within the same assay run. Reproducibility of 
both	assays	was	determined	by	calculating	inter-assay	CV	for	five	different	jejunal	
fluid	and	faecal	extracts	each	of	which	were	analyzed	on	10	consecutive	assays	on	
10	different	days.	Aliquots	of	jejunal	fluid	and	faecal	extracts	were	prepared	and	
placed in the freezer for the 10 consecutive assay runs to conduct reproducibility 
testing for both assays. 
A	Spearman	rank	sum	correlation	coefficient	(rho)	was	used	to	calculate	the	
relationship between observed and expected cTLI and cPLI concentrations in faecal 
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and	jejunal	fluid	extracts	 for	the	validation	of	 the	parameters	for	the	dilutional	
parallelism and spiking recovery, respectively. The odds ratio (oR) and the 95% 
confidence	intervals	(CI)	were	also	calculated	for	these	parameters.	For	all	statistical	
tests	significance	was	set	at	p < 0.05.
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4 rEsults
All dogs allocated into this research were vaccinated at six months and dewormed 
at two months before the trial commenced. All dogs ate all the food treatment 
meals at every time-point and therefore the food intake effectively equaled that of 
the dry weight of the food given to each dog. The dogs allocated in the study were 
rather large-framed Beagles. Visual assessment of the dogs ascertained that they 
were not overweight at the beginning of the study. The study lasted for almost six 
months. During that time all dogs maintained their good health, they were housed 
individually indoors and they were not allowed access to the common walking 
ground	in	order	to	avoid	coprophagia,	fights	and	other	disturbances.
4.1 %g+c profIlIng of dna samples In faeces (I)
Isolated bacterial DNA from canine faecal samples obtained during the feeding 
of	one	of	the	three	specialized	diets	was	used	for	%G+C	profiling	and	sequencing	
of	valid	 fractions	(referred	to	herein	as	 fractions	5,	10	and	14)	 from	the	%G+C	
profile.	Fractions	5,	10	and	14	corresponded	to	%G+C	ranges	of	27–32,	46.5-51.5	
and 62–67, respectively.
Samples of faeces taken from dogs fed the DC diet (p = 0.003, Figure 1) had a 
higher	abundance	of	microbes	with	the	%G+C	values	between	33	and	41	as	compared	
to	the	HPGM	diet	samples.	Figure	1	shows	that	%G+C	profile	data	of	faecal	samples	
taken from dogs on the HPgM diet manifested a shoulder between the values of 
46 and 50, which was completely lacking in the faeces of dogs fed the DC diet (p 
=	0.02,	Figure	1).	A	low	shoulder	of	%G+C	was	obtained	for	the	HPGM	diet	but	
was	lacking	for	the	DC	diet	samples	between	the	%G+C	range	of	25-29	(p = 0.05, 
Figure 1). 
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figure 1. %G+C profiles and fractions 5, 10 and 14 in the faeces of dogs fed the DC, HPGM and HCS diets (I).
The	profiles	were	different	at	%G+C	39-40,	57-58	and	65-66	between	the	DC	and	
HCS diets (p < 0.05, Figure 1). 
A	direct	comparison	of	the	faecal	%G+C	values	between	the	HPGM	and	HCS	
diet	revealed	that	there	are	considerable	differences	in	the	%G+C	profiles	(Figure	
1), whereby the HCS diet resulted in a higher abundance of faecal microbes with 
%G+C	between	33	and	40	as	compared	to	the	HPGM	diet	(p < 0.01, Figure 1). 
The	shoulder	peak	for	HPGM	diet	samples	at	faecal	%G+C	range	between	46	and	
50 was completely absent in the faeces of dogs fed the HCS diet samples plot (p 
=	0.02,	Figure	1).	In	contrast,	the	HCS	diet	favoured	faecal	bacteria	with	%G+C	
values higher than 60 (p < 0.05, Figure 1). 
4.2 phylogenetIc analysIs of fractIon 5 sequences In  
 faeces (I)
Ninety-six	sequences	per	sample	were	obtained	from	%G+C	fraction	5.	Clostridiales 
was the most representative bacterial order in faecal samples for both DC at 78% 
and HCS at 85% of clones. overall, the percentage of Clostridiales sequences in 
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faecal samples for the HPgM diet was much lower (37%, Figure 2). This difference 
in	faecal	microbes	was	statistically	significant	for	order	 level	 library	comparison	
analysis between the HPgM and DC diet and also in HCS and DC diet comparison 
(p < 0.01). 
figure 2. Phylogenetic analysis of fraction 5 sequences in faecal samples o five Beagles fed DC, HPGM 
and HCS diets (I).
Classification	of	the Clostridiales clones in the faeces of dogs fed  DC diet at family 
level were distributed between two main bacterial families i.e. Lachnospiraceae 
(72% of Clostridiales clones) and Peptostreptococcaceae (24% of Clostridiales 
clones) whereas in faecal samples for the HCS diet a great majority of clones 
(99% of Clostridiales	clones)	were	affiliated	with	Peptostreptococcaceae. Similar 
distribution in faecal microbes distributions as with the HCS diet was observed in 
HPgM diet, in which 94% of the Clostridiales	clones	were	also	classified	into	the	
family Peptostreptococcaceae family (Figure 2).
In the HPgM diet sample Fusobacteriales was the most prevalent order (62% 
of clones, Figure 2). Interestingly, only one clone of Fusobacteriales was found in 
the faeces of a dog on the HCS diet and none were detected when the dogs were 
fed the DC diet. The sequences belonging to the order Fusobacteriales showed the 
closest similarity with Fusobacterium varium and Fusobacterium mortiferum. 
In addition to the members of Clostridiales, 14% of the sequenced clones in the 
faeces	of	dogs	on	the	HCS	diet	were	affiliated	with	the	order	Erysipelotrichales 
(Figure	2),	which	is	classified	into	the	same	phylum	as	Clostridiales. More	specifically	
these sequences belong to the Clostridium cluster XVIII. In contrast, only one 
sequence	that	classified	into	the	order	Erysipelotrichales was discovered in faeces 
of dogs fed the HPgM diet (Figure 2).
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The sequence diversity in the faeces for the DC diet was generally higher 
when compared to faecal samples for the HCS and HPgM dietary treatments. 
The	DC	treatment	sequences	were	classified	 into	five	different	orders	of	which	
Lactobacillales and Bacteroidales were completely absent in the faeces of dogs fed 
HCS and HPgM diets (Figure 2). At the family level all Lactobacillales sequences 
affiliated	with	Streptococcaceae and Bacteroidales sequences with Prevotellaceae, 
respectively.
4.3 phylogenetIc analysIs of fractIon 10 sequences  
 In faeces (I)
Ninety-six	sequences	per	sample	were	obtained	from	%G+C	fraction	10.	Sequences	
that	affiliated	with	Clostridiales predominated in the faeces for the HPgM and 
HCS	diets	(93	and	90%	of	all	clones,	respectively).	At	 family	 level	classification	
the Clostridiales sequences for the HPgM diet treatment distributed mainly 
between Lachnospiraceae (57% of Clostridiales clones), Peptostreptococcaceae 
(35% of Clostridiales clones) and Ruminococcaceae (6% of Clostridiales clones). 
In contrast, the majority of Clostridiales sequences in the faeces for the HCS diet 
(96% of Clostridiales	clones)	were	classified	as	the	family	Peptostreptococcaceae 
(Figure 3). A	total	of	85.5%	these	sequences	affiliated	with	the	Cl. hiranonis, which 
is a member of Clostridium cluster XI. 
figure 3. Phylogenetic analysis of fraction 10 sequences in the faeces of dogs fed DC, HPGM and HCS diets (I).
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The abundance of Clostridiales sequences (44%; mainly members of family 
Lachnospiraceae) for dogs on the DC diet was smaller in comparison to the faecal 
HPgM and HCS diet treatments (Figure 3, p < 0.01). The most dominant group 
of bacteria with fraction 10 for the DC diet was Lactobacillales,	more	specifically 
Streptococcaceae, which comprised 54% of the clones sequenced. only two 
Streptococcaceae clones were found in the HPgM diet sample and no lactic acid 
bacteria were detected in the faeces of dogs fed the HCS diet sample (Figure 3).  
4.4 phylogenetIc analysIs of fractIon 14 sequences  
 In the faeces (I)
Forty-eight	sequences	per	sample	were	obtained	from	%G+C	fraction	14.	All	141	
clones	from	the	high	%G+C	fraction	14	that	yielded	a	sequence	of	adequate	quality	
were	affiliated	with	the	order	Coriobacteriales (Figure 4). The majority of clones 
(n=138) at genus level appeared to belong to the Collinsella spp. and the remaining 
clones represented Slackia spp. and Eggerthella spp. Surprisingly, members of 
the order Bifidobacteriales were not detected in any of the three faecal samples.
figure 4. Phylogenetic analysis of fraction 14 sequences in the faeces of five dogs fed DC, HPGM and 
HCS diets (I).
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4.5 clInIcal parameters, bacterIa-derIVed metabolIc  
 products and canIne faecal calprotectIn (II)
The faecal consistency score was increased during the HPgM diet period (p < 0.01), 
where all dogs had diarrhoea. Faecal pH was increased for the HPgM and the HCS 
diets compared with the DC diet (p < 0.01). Faecal ammonia concentrations were 
(p = 0.01) lower for the HCS diet than for either the HPgM or the DC diet feeding 
periods (Table 6).
The total VFA concentrations were lowest (p < 0.01) for the HPgM diet, which 
was partly due to the lower concentrations of acetic acid (p < 0.01) and of propionic 
acid (p < 0.01). Valeric acid and the BCFA concentrations that were measured in 
the faeces were found to be higher for the HPgM diet (p < 0.01 and p = 0.02, 
respectively) compared with the DC and HCS diets. The faecal canine calprotectin 
concentrations remained within the established reference interval (Heilmann et 
al., 2008a,b), but were higher for the HPgM diet (Kruskal-Wallis test, p = 0.01) 
than either the HCS or the DC diet, and they correlated positively with valeric acid 
(p < 0.01).
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table 6. Analysis of body weight and faecal consistency scores, dry matter, pH, ammonia (NH3), VFA and 
calprotectin concentrations (n=3 faecal samples for each variable per diet period) of five dogs. Values are 
expressed as medians and ranges [min–max]. For each variable, diets not sharing a common superscript 
are significantly different for p-values below 0.05 and are marked in bold (II).
variable baseline 
(dc)
dc1 hpgm 2 hcs 3 kruskal-
wallis
p-value
mixed 
model
p-value
body weight, 
kg
19.0 
[18.3-
19.3] A 
19.78 [18.15-
21.10]A
20.00 
[18.60-
21.65] A
19.40 
[18.80-
20.85] A 
> 0.10 > 0.10
faecal 
consistency 
score
2.5
[2.0- 
3.0] B
2.5
[2.0-3.0] B
4.0
[4.0-
5.0] A
2.5
[2.0-
3.0] B
< 0.01 < 0.01
faecal dry
matter, %
32.2
[30.1-
36.2] A
32.4
[30.6-35.4] A
32.2
[13.6-
35.9] A
32.5
[29.8-
35.7] A
> 0.10 > 0.10
faecal ph 6.9
[6.8-7.1] 
B,C
6.7
[6.5-7.0] C
7.5
[6.6-
7.9] A
7.2
[7.0-7.5] 
A,B
< 0.01 < 0.01
faecal nh3,µg/g wet 
faeces
1 245
[982-1 
482] A
1 079
[693-1 468] A,B
1 191
[710-1 
778] A
835
[657-
1162] b
0.03 0.01
total vfa, 
mm
196
[165-221] A
195
[165-239] A
137
[75.0-
192] b
176
[152.3-
198] A
0.01 < 0.01
acetic acid, 
mm
118
[90.0-
135] A
118.9
[93.9-144] A
71.0
[47.8-
105] b
96.9
[83.5-111] 
A,B
< 0.01 < 0.01
propionic 
acid, mm
49.3
[45.3-
55.9] A
51.1
[33.5-63.8] A
25.2
[7.1-31.5] 
b
21.1
[14.0-
29.9] A
0.02 < 0.01
Butyric acid, 
mM
21.3
[14.8- 
27.8] A
21.3
[14.8-27.8] A
16.8
[9.0-
23.6] A
21.1
[14.0-
29.9] A
0.10 0.08
valeric acid, 
mm
0.4
[0.0-0.5] B
0.4
[0.0-0.8] B
9.8
[0.0-
15.3] a
0.6
[0.4-
6.6] B
< 0.01 < 0.01
bcfa,
mm
8.1
[6.8-12.1] 
A,B
8.3
[5.6-12.4] A,B
13.1
[2.2-
18.9] a
8.2
[5.5-
12.2] B
0.10 0.02
calprotectin, 
µg/g
4.6
[2.9-7.5] B
3.0
[2.9-20.6]  B
25.0
[12.0-
113.4] a
8.8
[5.7-22.9]
A,B
0.01 < 0.01*
  
1 DC: dry commercial diet
2 HPGM: high-protein greaves-meal diet
3 HCS: high-carbohydrate starch based diet
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4.6 ANALYTICAL VALIDATION OF RIAS FOR MEASURING CTLI  
 AND CPLI CONCENTRATIONS IN JEJUNAL FLUID AND   
 FAECAL SAMPLES (III)
A dilution factor of 1:8 was generally used for the samples to measure cTLI 
concentrations in jejunal fl uid and faeces. This dilution factor was derived after 
measuring TLI concentrations in all jejunal fl uid and faecal extracts at different 
dilutions and by evaluating the results based on the corresponding standard curve. 
O/E ratios for serial dilutions ranged from 77.0% to 103.4% (mean±SD 86.6±8.4%) 
for fi ve different jejunal fl uid extracts (Table 7). O/E ratios for the serial dilution of 
three different faecal extracts ranged from 87.2% to 114.8% (mean±SD 96.5±9.2%), 
and ranged from 89.3% to 116.9% (mean±SD 102.4±10.4%) for two different faecal 
extracts (Table 7). 
Table 7. Linearity of cTLI-RIA and cPLI-RIA. 
cTLI-RIAa cPLI-RIAb
Extract Dilutions
cTLI 
(μg/L) O/E±SD (%) Dilutions cPLI (μg/L) O/E±SD (%)
Chyme 1 1:8–1:64 121.1 88.3±10.4 1:1–1:8 201.6 92.1±4.6
Chyme 2 1:8–1:64 167.8 80.0±0.6 1:1–1:8 223.1 94.0±12.4
Chyme 3 1:8–1:64 172.6 81.0±6.6 1:2–1:16 287.1 96.7±16.5
Chyme 4 1:8–1:64 185.6 88.4±3.5 1:2–1:16 327.4 96.0±14.7
Chyme 5 1:8–1:64 216.2 95.4±9.6 1:2–1:16 375.9 88.8±7.8
Faecal 1 1:2–1:16 35.4 98.8±8.1 1:1–1:8 106.2 103.0±11.7
Faecal 2 1:2–1:16 43.0 101.9±11.2 1:1–1:8 130.3 115.0±3.7
Faecal 3 1:2–1:16 53.5  88.6±1.2 1:1–1:8 188.7 101.9±4.2
Faecal 4 1:4–1:32 94.5 100.3±7.9 1:1–1:8 211.3 100.7±13.4
Faecal 5 1:4–1:32 225.0 104.5±14.0 1:1–1:8 224.9 102.9±9.0
a The O/E for the serial dilution of cTLI in ﬁ ve chyme extracts diluted 1:8–1:64 ranged from 77% to 
103.4% (mean±SD: 86.6±8.4%). O/E ratios for the serial dilution of three different faecal extracts 
diluted 1:2–1:16 ranged from 87.2% to 114.8% (mean±SD: 96.5±9.2%), and ranged from 89.3% to 
116.9% (mean±SD: 102.4±10.4%) for two different faecal samples diluted 1:4–1:32. 
b The O/E for the serial dilution of cPLI ranged from 86.5% to 108.3% (mean±SD: 93.1±8.4%) 
for two different chyme extracts at dilutions of 1:1–1:8; and from 80.9% to 115.3% (mean±SD: 
93.8±12.3%) for three different chyme extracts at dilutions of 1:2–1:16. O/E ratios for serial dilutions 
ranged from 91.1% to 118.5% (mean±SD: 104.7±9.5%) for ﬁ ve different faecal extracts at dilutions 
of 1:2–1:8 (III).
O/E ratios for spiking recovery ranged from 79.0% to 111.2% (mean±SD 97.9±8.2%) 
for fi ve different jejunal fl uid extracts and from 74.6% to 111.3% (mean±SD: 
90.8±9.8%) for fi ve faecal extracts (Table 8). 
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Table 8. Accuracy of the cTLI-RIA and cPLI-RIA. 
cTLI-RIAa cPLI-RIAb
Extract cTLI (μg/L) O/E±SD (%)
cPLI 
(μg/L) O/E±SD (%)
Chyme 1 17.6     95.7±9.8 25.9   105.7±8.3
Chyme 2 23.5     94.1±9.9 54.0   104.1±14.4
Chyme 3 26.1     97.3±9.2 61.8    105.6±11.6
Chyme 4 33.8     97.4±2.8 63.2     93.3±5.1
Chyme 5 45.8   105.1±3.8 85.0   106.1±2.3
Faecal 1 7.5     91.8±14.7 32.1   104.2±12.2
Faecal 2 12.5     91.9±10.0 55.9    107.5±8.2
Faecal 3 17.9     88.9±7.4 85.1   100.1±6.9
Faecal 4 26.0     84.2±2.7 91.2   97.0±11.1
Faecal 5 33.6     97.2±8.4 95.4   96.7±12.3
a The results for spiking ﬁ ve different chyme and faecal extracts with ﬁ ve different concentrations 
of inactivated canine trypsin. O/E ratios obtained by spiking ﬁ ve chyme extracts ranged from 
79.0% to 111.2% (mean±SD: 97.9±8.2%) and of ﬁ ve faecal extracts that were obtained from 74.6% 
to 111.3% (mean±SD: 90.8±9.8%)
b The results for cPLI following the spiking ﬁ ve different chyme and faecal extracts with ﬁ ve 
different concentrations of canine pancreatic lipase. O/E ratios obtained by spiking ﬁ ve chyme 
extracts ranged from 85.4% to 120.0% (mean±SD: 103.0±10.0%) and of ﬁ ve faecal extracts from 
78.9% to 116.1% (mean±SD: 101.1±10.5%) (III).
Intra-assay CV for fi ve different jejunal fl uid extracts and fi ve different faecal extracts 
were ≤ 6.6% and ≤ 10.8%, respectively (Table 9). Inter-assay CV for fi ve different 
jejunal fl uid extracts and fi ve different faecal extracts were ≤ 10.0% and ≤ 9.0%, 
respectively (Table 9).
Table 9. Repeatability and reproducibility of the cTLI-RIA.
 ChymeExtract
Mean
(μg/L) CV (%)
Faecal
Extract
mean
(μg/L) CV (%)
 1 128.9   5.5 1   21.1 10.8
 2 130.3   2.2 2   44.6   6.2
Intra-assay 3 190.4   5.8 3   56.2   6.1
variability 4 244.3   6.6 4   111.2   9.3
 5 295.2   4.4 5 142.0   5.2
 1   62.9   8.7 1   21.9   9.0
 2 131.7   7.8 2   29.1   6.9
Inter-assay 3 137.0   8.6 3 235.7   6.0
 variability 4 234.9   8.8 4 270.5   8.9
 5 354.7 10.0 5 362.0   4.4
Results 
58
The	 table	 shows	 intra-assay	 variability	 of	 CV;	 repeatability	 for	 five	 different	
chyme	extracts	and	five	different	faecal	extracts,	which	were	≤6.6%	and	≤10.8%,	
respectively.	Inter-assay	variability	of	CV;	reproducibility	for	five	different	chyme	
extracts	and	five	different	 faecal	extracts	were	≤10.0%	and	≤9.0%,	respectively	
(III). The in-house cPLI-RIA yielded reproducible concentrations with tracers from 
three different iodinations, indicating reliable binding of 125I to the protein. The 
lower	detection	limit	(analytical	sensitivity)	of	the	cPLI-RIA	was	11.9	μg/L.	The	
cPLI	concentrations	detected	in	jejunal	fluid	and	faecal	extracts,	entailed	that	both	
specimens were analyzed in a 1:2 dilution, which was considered adequate for the 
sample used in this study. Evaluation of the adequate dilution was based on the 
different	jejunal	fluid	and	faecal	extract	PLI	concentrations	and	the	corresponding	
standard curve. The o/E ratios for serial dilutions ranged from 86.5% to 108.3% 
(mean±SD	93.1±8.4%)	for	 two	different	 jejunal	fluid	extracts,	and	from	80.9%	
to	 115.3%	 (mean±SD	93.8±12.3%)	 for	 three	other	 jejunal	fluid	extracts	 (Table	
7). The o/E ratios for serial dilutions ranged from 91.1% to 118.5% (mean±SD 
104.7±9.5%)	for	five	different	faecal	extracts	(Table	7).	The	O/E	ratios	for	spiking	
recovery	ranged	from	85.3%	to	120.0%	(mean±SD	103.0±10.0%)	for	five	different	
jejunal	fluid	extracts	and	from	78.9%	to	116.1%	(mean±SD:	101.1±10.5%)	for	five	
faecal	extracts	at	a	1:2	dilution	(Table	8).	Intra-assay	%CV	for	five	different	jejunal	
fluid	extracts	and	five	different	 faecal	extracts	were	≤	7.6%	and	≤	8.6%	(Table	
10).	Inter-assay	CV	for	five	different	jejunal	fluid	extracts	and	five	different	faecal	
extracts	were	≤	9.8%	and	≤	8.1%	(Table	10).
table 10. Repeatability and Reproducibility of the cPLI-RIA.
chyme 
Extract mean (µg/l)  cv (%)
faecal 
Extract
mean 
(µg/l) 
 cv 
(%)
1 143.9 7.6 1   49.2 8.6
2 211.3 4.2 2   55.5 6.6
intra-assay 3 295.6 3.0 3   98.5 2.8
variability 4 354.4 4.6 4 121.4 3.1
5 440.7 2.6 5 155.0 3.2
1 129.8 8.9 1   44.6 8.1
2 145.0 9.8 2   55.7 7.6
inter-assay 3 208.3 7.1 3   94.5 6.0
variability 4 255.7 8.1 4 133.0 4.7
5 328.0 7.7 5 154.3 6.8
The	table	shows	intra-assay	variability	(CV;	repeatability)	for	five	different	chyme	
extracts	and	five	different	faecal	extracts,	which	were	≤7.6%	and	≤8.6%.	Inter-assay	
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variability	(CV;	reproducibility)	for	five	different	chyme	extracts	and	five	different	
faecal	extracts	were	≤9.8%	and	≤8.1%	(III).	Statistical	analysis	revealed	a	significant	
correlation between the observed and expected concentrations of cTLI and cPLI 
in	jejunal	fluid	and	faecal	extracts	for	both	analytical	validation	parameters	(e.g.	
dilutional	parallelisms	and	spiking	recovery;	for	all:	Spearman	correlation	coefficient	
ρ	≥	0.97;	p < 0.001).
4.7 amylase, cplI, ctlI and ce1 In serum, jejunal fluId  
 and faecal samples (IV)
No	significant	effect	of	diet	could	be	identified	for	serum	cTLI	and	cPLI	concentrations.
Jejunal	fluid	amylase	activities	and	jejunal	fluid	cPLI	concentrations	were	lower	
for dogs fed the HCS diet than those fed the HPgM or the DC diets (p = 0.04 and 
p	=	0.03,	respectively,	Table	11,	Figure	5	and	6).	No	significant	dietary	effect	for	
jejunal	fluid	cTLI	or	cE1	concentrations	could	be	identified	(Table	11,	Figures	7).
Dogs	fed	the	HPGM	diet	had	significantly	lower	faecal	cPLI	and	cE1	concentrations	
(p < 0.01 and p = 0.02, Table 11, Figures 6 and 7) when compared to the DC and 
HCS	diets.	This	was	in	contrast	to	jejunal	fluid	cE1	and	cPLI	concentrations,	for	
which	no	differences	could	be	identified.		Despite	there	being	a	lower	jejunal	cPLI	
concentration when the dogs were on the HCS diet there was no evidence that 
faecal	cPLI	concentrations	were	correspondingly	influenced	by	dietary	changes.
Results 
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table 11. cTLI concentration, cPLI concentration in serum, amylase activity and cTLI, cPLI, and cE1 
concentrations jejunal fluid, and cTLI, cPLI, and cE1 concentrations in the faeces of five dogs. Values are 
expressed as medians and ranges [min–max]. For each variable, diets not sharing a common superscript 
are significantly different at p < 0.05 and are marked in bold (study IV).
variables / 
diet
baseline 
(dc)
dc1 hpgm 2 hcs 3 anova 
p-value
kruskal-wallis 
p-value
Jejunal 
fluid 
amylase 
(u/l)
89.7 
[69.2-
122]A,B
75.3 
[48.9-
109.3]
A,B
84.7 
[79.2-
189]B
27.5 
[22.9-
64.6]a
0.07 0.04
Jejunal 
fluid ctli 
(µg/l)
210 
[93.5-
318]A
166 
[80.4-
218]A
213
[131-
237]A
124 
[73.1-
170]A
NS  NS
Jejunal 
fluid cpli 
(µg/l)
272 
[266-
375.1]B
205.2
[165.3-
232.4]
A,B
270.8 
[210.7-
334]A,B
186.1 
[118.2-
241]a
0.06 0.03
Jejunal 
fluid cE1 
(µg/g)
169 
[144-
174]A
151 
[138-
166]A
168 
[153-
177]A
154 
[132-
173]A
 NS NS
faecal ctli 
(µg/l)
152 
[24.2-
285]A
63.2 
[25.3-
453]A
81.2 
[18.2-
498]A
137 
[11.7-
443]A
NS NS 
faecal cpli 
(µg/l)
98.8 
[70.9-
149.9]B
79.6 
[61.2-
176.1]B
61.9 
[50.6-
87.7]a
129 
[80.4-
147]B
< 0.01 < 0.01
faecal cE1 
(µg/g)
109
[72.0-
130]A,B
164 
[99.4-
192]B
51.6 
[44.1-
191]a
167 
[108-
197]B
0.02 0.04
serum cpli 
(µg/l)
39.0
[15.0-
57.0]A
43.0 
[15.0-
135]A
15.0
[15.0-
295]A
55.0 
[15.0-
58.0]A
NS NS 
serum ctli 
(µg/l)
7.60 
[6.30-
9.50]A
8.00 
[6.10-
8.40]A
9.10 
[6.40-
11.3]A
6.80 
[5.60-
10.1]A
NS  NS
 
1 DC: dry commercial diet; 2 HPGM: high-protein greaves-meal diet; and 3 HCS: high-carbohydrate 
starch based diet
NS: non-significant
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figure 5. Canine amylase activities in jejunal fluid of five healthy dogs fed three different diets (DC, HPGM, 
or HCS). The lines represent the medians (IV).
* significantly different at p < 0.05
1 DC: dry commercial (DC) diet
2 HPGM: high-protein greaves-meal diet
3 HCS: high-carbohydrate starch based diet
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figure 6. Canine cPLI concentrations in jejunal fluid and faeces in five healthy dogs fed three different 
diets (DC, HPGM, or HCS). The lines represent the medians (IV).
* significantly different at p < 0.05
1 DC: dry commercial (DC) diet
2 HPGM: high-protein greaves-meal diet
3 HCS: high-carbohydrate starch based diet
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figure 7. Canine elastase concentrations in jejunal fluid and faeces in five dogs fed three different diets 
(DC, HPGM, or HCS). The lines represent the medians (IV).
* significantly different at p < 0.05
1 DC: dry commercial (DC) diet
2 HPGM: high-protein greaves-meal diet
3 HCS: high-carbohydrate starch based diet
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5 discussion
5.1 anImals and study desIgn (I-IV)
In the current study the incomplete graeco Latin square design was used. The design 
allowed	five	healthy	Beagle	dogs	with	permament	jejunal	fistulas	(Harmoinen	et	al.	
2001) to be enrolled. It is stated in the European Union (EU) Directive 86/609/EEC 
that the European Commission and the EU member states must actively encourage 
and support the development, validation, and acceptance of models, which could 
reduce,	refine	or	replace	the	use	of	 laboratory	animals.	It	would,	thus	be	highly	
desirable to follow this principle by decreasing the numbers of animals needed for 
experimentation and yet obtain accurate data of a given amount and precision. 
It is possible to achieve this by adopting the most optimum statistical design to 
obtain trustworthy results.  other researchers have carried out studies with up to 
six dogs (greetham et al. 2002; Suchodolski et al. 2008a,b, 2009; Middelbos et al. 
2010; Swanson et al. 2011). These studies also complied with the above-mentioned 
guidelines.
An	animal	model	comprising	Beagles	that	had	been	fistulated	with	a	 jejunal	
nipple valve were used to analyze the digestive enzymes in the contents of the small 
intestine. Information on the small intestinal microbiota and digestive enzymes of 
the dogs is rather limited as the main obstacle is the regular access to adequate chyme 
samples.	There	have	been	many	difficulties	with	the	laparotomy	and	endoscopy	
methods, which require general anaesthesia, which in turn entails that the dogs 
must fast before-hand and eventually leads to minimal volumes of jejunal samples 
being taken. The laparotamy and endoscopy methods are also time-consuming, 
which	makes	 frequent	 sampling	 very	 difficult	 to	 execute.	Cannulation	models	
have been reported to have considerable complications: especially with foreign 
material rejection, abscesses, cannula extrusion, and ulceration of the skin due to 
the presence of the foreign material in the intestine (Hill et al. 1996; Harmoinen 
et	al.	2001).	Sampling	through	the	jejunal	nipple	valve	fistulas	were	performed	in	
conscious dogs, with no discomfort or pain to the animal. It has also been found that 
the	jejunal	nipple	valve	fistula	does	not	change	the	compostition	of	the	intestinal	
microbiota nor is the intestinal transit time of the intestinal content or the intestinal 
permeability altered (Harmoinen et al. 2001; Frias et al.,2010). This dog model has 
been successfully used in various studies (Mentula et al. 2005; Suchodolski et al. 
2009; Frias et al. 2010).
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5.2 canIne mIcrobIota (I), bacterIa-derIVed metabolIc  
 products (II) and dIgestIVe enzymes (III, IV)
The	intestinal	microbiota	is	an	extremely	complex	system,	which	is	influenced	by	
different factors such as health of the host and its digestive tract, diet, digestive 
enzymes. It is well known, that those bacteria that can most rapidly degrade and 
use the digesta will proliferate in numbers beyond those of the less active species 
(Cummings & Macfarlane 1991; Salonen & de Vos 2014; Zoetendal & de Vos 2014). 
In	this	current	reasearch	the	 influence	of	 the	diet	on	the	 intestinal	microbiota,	
bacteria-derived metabolic products and digestive enzymes were evaluated.  The 
source, amount and type of macronutrients that arrive in the intestine are the main 
factors	that	influence	the	fermentation	characteristics,	abundance	and	variety	of	
the resident bacterial populations at various sites (Morita et al. 2004; Wong et al. 
2006; Hooda et al. 2012) and digestive enzymes i.e., amylase, proteases, and lipases 
(Kern et al. 1987; Brannon 1990). The adaptation of exocrine pancreatic secretions 
to nutritional changes has been investigated in various species, especially in rats 
(Stock-Damge et al. 1984; Chowdhury et al. 2000; Li et al. 2004; Lee et al. 2006). 
In dogs, however, the adaption of pancreatic secretion due to diet has been scarcely 
examined (Stock-Damge et al. 1984; Ballesta et al. 1990; Manas et al. 1996; Yago et 
al. 1997; James et al. 2009) over the last 30 years. Maize and greaves-meals were 
used in the current study as a source of carbohydrate and protein. 
There	was	no	evidence	of	any	influence	by	any	of	the	three	diets	on	the	following	
parameters: food intake, body weight, faecal dry matter of the dogs differently in 
Study	II,	or	on	serum	concentrations	of	cTLI	and	cPLI	in	Study	IV.	These	findings	
are	consistent	with	a	previous	study,	which	assessed	the	influence	of	dietary	fat	on	
serum cTLI and cPLI concentrations (James et al. 2009). The authors of that study 
concluded that the serum enzyme concentrations did not differ when feeding diets 
of different fat compositions for one week with or without supplemental pancreatic 
enzymes and medium-chain triglycerides.
5.2.1 hIgh-carbohydrate starch-based dIet
The	modulatory	influence	of	HCS	diet	on	canine	faecal	microbiota	in	Study	I	was	
smaller than that of the HPgM diet when compared to the DC diet phase of the 
trial	as	the	%G+C	profiles,	and	the	order	 level	sequence	distribution	in	fraction	
five	samples	between	the	DC	and	HCS	diet	did	not	differ	considerably.	The	most	
abundant sequences in the faeces of dogs on the HCS diet in Study I belonged to the 
order Clostridiales, and had the closest similarity with Clostridium hiranonis, which 
was reported in the canine gastrointestinal tract and is considered to be typical of 
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canine intestinal microbiota (Mentula et al. 2005; Suchodolski et al. 2008a, 2009; 
Middelbos et al. 2010; Handl et al. 2011; Hand et al. 2013; Beloshapka et al. 2013). 
Both, DC and HCS diets consisted mainly of carbohydrate-rich components. 
Although corn starch is easily digestible and is not expected to reach the large 
intestine, an earlier study in rats indicated that carbohydrate did indeed affect 
the composition of faecal bacteria as determined by the denaturing gradient gel 
electrophoresis banding pattern (Licht et al. 2006). Therefore, it is possible that 
the passage of corn starch into the large intestine was one of the main reasons 
for sequence differences between the DC and HPgM diets over and above the 
differences obtained between the HCS and HPgM diets. The decrease in ammonia 
levels	when	feeding	the	HCS	diet	 in	Study	II	could	be	explained	by	a	sufficient	
carbohydrate supply to the large intestine in dogs fed the HCS diet, which led to a 
decrease in luminal nitrogenous compounds or by a decreased amount of protein 
that reached the hindgut for subsequent fermentation (Cummings et al. 1979; Wong 
et al. 2006; Jha & Leterme 2012; Nery et al. 2012). 
A	suprising	finding	in	Study	IV	was	that	the	amylase	activity	 in	 jejunal	fluid	
was lowest when the dogs were fed the HCS diet. Previous studies with various 
animals that included rats, pigs, and dogs reported that the activities of amylase in 
the acinar cells and pancreatic juice increased when a carbohydrate-rich diet was 
fed for seven days for rats, four weeks for pigs, or 48 weeks for dogs (Johnson et 
al. 1977; Poort & Poort 1981; Stock-Damge et al. 1984; Flores et al. 1988; Takaori 
et al. 1995; Chowdhury et al. 2000; Lee et al. 2006). Similar results were obtained 
by an early study in dogs over a one-month treatment period (Stock-Damge et al. 
1984). It is noteworthy that the amylase activity found in Study IV was investigated 
in	the	jejunal	fluid	and	not	in	the	acinar	cells	or	in	pancreatic	juice	as	was	done	in	
previously cited studies (Stock-Damge et al. 1984; Flores et al. 1988; Chowdhury 
et al. 2000; Lee et al. 2006). Another explanation could be the lower levels of 
protein in the HCS diet, possibly followed by a decreased protein synthesis and 
reduced amylase synthesis, which have been reported to be the case in rats fed a 
low-protein	diet	(Schick	et	al.	1984).	It	can	also	be	speculated	that	the	jejunal	fluid	
sampled during the HCS diet period contained higher amounts of amylase activity 
binding substances, which provides less enzyme activity for the colorimetric assay. 
Studies that compare enzyme activity determinations using colorimetric methods 
with RIA or ELISA based determinations of enzyme concentrations are needed to 
support this hypothesis, however. 
The	jejunal	fluid	cPLI	concentrations	were	lower	when	the	HCS	diet	was	fed	
compared to when the dogs were fed the DC or HPgM diets in Study IV.  An early 
study in pigs suggested that the release of pancreatic lipase is dependent on the 
amount and type of dietary fat and also on the duration of feeding (Deschodt-
Lanckman et al. 1971). That same study also reported a two-fold greater response 
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by pancreatic lipase for unsaturated fats than for saturated fats. However, a later 
study found that the degree of fat saturation had no effect on lipase activity per se, 
but	that	the	length	of	the	fatty	acid	chain	did	influence	lipase	activity	in	the	pancreas	
(Saraux et al. 1982). There also appeared to be differences between short-term 
and long-term adaption of pancreatic lipase secretion. Short-term feeding of a diet 
rich in carbohydrates and fat for eight days to dogs did not cause any discernible 
changes in the expression and secretion of pancreatic lipase in pancreatic juice 
(Manas	et	al.	1996).	In	contrast,	feeding	a	diet	containing	8%	sunflower	oil	to	dogs	
for 32 weeks led to an increased secretion of lipase into their respective pancreatic 
juice (Ballesta et al. 1990). In Studies I-IV, the crude fat content in the HCS diet 
was 133 g/kg, which was intermediate between those of the DC (100 g/kg) and the 
HPgM (150 g/kg) diets. Therefore, the total amount of fat in the diet cannot explain 
the	findings	in	Study	IV.	The	duration	of	feeding	did	not	differ	between	the	diets	
either,	thus	it	is	possible	that	the	type	of	dietary	fat	might	have	an	influence	on	the	
measurements of pancreatic enzyme secretion. It is one of the limitations of this 
study	that	dietary	fatty	acid	profiles	were	not	analyzed	to	validate	this	deduction.	
However,	the	principal	object	of	this	study	was	to	focus	specifically	on	the	influence	
of carbohydrates and proteins on the secretion of pancreatic enzymes.
A	surprsing	finding	in	Study	IV	was	that	jejunal	fluid	cPLI	concentration	was	
decreased whereas faecal cPLI concentration was increased when dogs were fed the 
HCS	diet.	This	finding	could	be	due	the	resorption	of	water	during	the	passage	of	
the digesta through the colon or because of increased levels of undigested dietary 
corn starch and fat reaching the colon. However, the recorded differences in jejunal 
and faecal cPLI and cE1 concentrations led to the conclusion that faecal enzyme 
concentrations	do	not	appear	to	reflect	jejunal	conditions	directly	and	that	dietary	
composition might be one reason for such differences.
5.2.2 hIgh-proteIn greaVes-meal dIet
The HPgM diet fed in Study II led to diarrhoea in all dogs. The greaves-meal diet 
is known to soften the consistency of faeces, increase the Clostridium perfringens 
levels	and	decrease	bifidobacteria	 in	dogs	(Zentek	1995a,b,c;	Dong	et	al.	 1996;	
Meyer et al. 1999; Zentek et al. 2003, 2004). A study by Zentek et al., that used 
a culturing method showed increased numbers of Clostridium perfringens in 
dogs	fed	animal	protein	as	poultry	or	beef	(Zentek	et	al.	2004).	Such	a	finding	
is consistent with an increased number of C. perfringens colonies and decreased 
counts of Bifidobacterium species reported in dogs and cats that were fed a low-
quality protein diet (Zentek et al. 2003; Hooda et al. 2013). The faecal samples 
obtained from dogs fed the high-protein greaves-meal diet in Study I contained 
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bacterial species that belonged to the orders Clostridiales, Coriobacteriales, and 
especially members of the order Fusobacteriales – the most abundant sequences 
in	fraction	five.	Sequences	belonging	to	the	order	of	Fusobacteriales showed close 
similarity with the species F. varium and F. mortiferum. It is known from human 
research that F. varium and F. mortiferum can be at the same time commensals 
and opportunistic pathogens (Swidsinksi et al. 2011). Several Fusobacterium species 
i.e., F. varium, F. necrophorum, F. nucleatum, F. equinum have been found to 
play	a	crucial	role	 in	many	different	 inflammatory	processes,	 including	colonic	
inflammation	(Citron	2002;	Ohkusa	et	al.	2009;	Swidsinski	et	al.	2011).	
The high levels of greaves-meal fed in Study II led to a decrease in total VFAs 
that were mainly attributable to decreases in acetic and propionic acids. In contrast, 
the concentration of faecal valeric acid increased for the HPgM diet. It has been 
shown in other studies that there are differences between protein sources in terms of 
fermentation end products (Depauw et al. 2012), which result in higher proportions 
of valeric and acetic acids in the canine colon arising from the fermentation of 
undigested proteins (Kuzmuk et al. 2005). Acetic acid is produced and excreted 
by the fermentation activities of acetic acid producing bacteria, e.g., Acetobacter, 
B. subtilis (Cheryan 2000).  The decrease in faecal acetic acid reported in Study II 
for the HPgM diet could be associated with: a) a lower amount or activity of acetic 
acid-producing bacteria in the colon due to reduced levels of carbohydrate or reduced 
levels of hydrogen and carbon dioxide; or b) it could be due to the high amounts 
of greaves-meal entering the large intestine suppressing the acetate production. It 
could also be a combination of both a) and b).
The faecal BCFA were increased in dogs fed the HPgM diet. It is generally 
known that BCFA are formed by the metabolism of branched-chain amino acids 
such as valine, leucine, and isoleucine following the breakdown of polypeptides 
(Macfarlane et al. 1992; Tjellström et al. 2005). Therefore, the increase in faecal 
BCFA measured for the HPgM diet might be simply due to the large amounts of 
protein entering the hindgut. An increase in the concentration of BCFA in faeces has 
also been reported in humans who were fed a diet containing supplemental dietary 
protein based on whey, casein, and lactalbumin (geypens et al. 1997; Nyangale et 
al. 2012; Salonen & de Vos 2014).
The calprotectin levels were increased in the faeces of dogs fed the HPgM diet 
in Study II and they were also positively correlated with the concentration of faecal 
valeric	acid.	Calprotectin	was	also	reported	to	be	a	sensitive	but	nonspecific	biomarker	
of	intestinal	inflammation	in	human	medical	studies	(Melling	et	al.	1996;	Tibble	et	
al. 1999). Later studies suggest that this is because the calprotectin parameter is 
not	sensitive	enough	for	the	definitive	differentiation	between	underlying	intestinal	
diseases (Roseth et al. 1993, 2004; Fagerhol 2000). Increased concentrations of 
faecal calprotectin were also detected in patients with Crohn’s disease (Tibble et al. 
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2000; Roseth et al. 2004), ulcerative colitis (Fagerhol 2000), and colorectal cancer 
(Roseth et al. 1993). Increased concentrations of faecal and serum calprotectin 
have been detected in dogs with chronic diarrhoea and IBD (Heilmann et al. 2012; 
grellet et al. 2013).  In addition to calprotectin, there is another member of the 
calgranulins named calgranulin C (S100A12), which has been associated with the 
severity	of	colonic	inflammation.	A	recent	study	detected	elevated	faecal	S100A12	
concentration in dogs with IBD (Heilmann et al. 2010, 2011a, 2014).
None of the three diets fed in this study appeared to cause differences in faecal 
cTLI concentrations but faecal cPLI and cE1 concentrations were lower when feeding 
the	HPGM	diet	as	reported	in	Study	IV.	The	concentrations	of	cTLI	in	jejunal	fluid	
or in faecal samples did not differ between diets therefore it seems reasonable to 
conclude that dogs appear to have only a limited capacity to adjust their pancreatic 
cTLI secretions in response to different amounts of protein in the diet over a three 
week period. 
Interestingly,	cPLI	and	cE1	concentrations	 in	 jejunal	fluid	were	not	affected	
by dietary changes in this study, whereas their respective concentrations in faeces 
were lower when fed the HPgM diet. Possible explanations for this discrepancy 
are dilution effects due to increased faecal water in diarrhoeic dogs, or because of 
the binding of cPLI and cE1 to components of the faecal matrix that renders them 
unavailable for binding with antibodies during the assays. It was reported in Study 
II that feeding the DC, HCS and HPgM diets did not have an effect on faecal dry 
matter despite the development of diarrhoea in all dogs on the HPgM diet. It could 
be	speculated	that	the	reason	for	the	differences	not	being	statistically	significant	
could be due to the large variation in moisture between faecal samples within the 
same dietary sampling period and also because of the small number of dogs (n=5) 
used in the study. However, dilution can be a major reason for decreased faecal 
marker concentrations despite there being comparably similar jejunal cPLI and 
cE1 concentrations (Spillmann et al. 2000; Steiner et al. 2010). This might also be 
a possible explanation for the previously reported occurrence of abnormally low 
faecal cE1 concentrations in healthy dogs and also in dogs with chronic diarrhoea 
that had not been caused by EPI (Spillmann et al. 2000, Wiberg et al. 2000, Steiner 
et al. 2010). The binding of cPLI and cE1 to the faecal matrix that led to decreased 
availabilities of these antigens for their respective assays is a rather speculative 
explanation,	but	 it	 is	based	on	the	finding	that	 lipase	activity	 is	affected	by	the	
dietary	fiber	content	(Dutta	&	Hlasko	1985,	Westermarck	&	Wiberg	2006).	In	the	
Studies	I-IV,	the	HPGM	diet	contained	more	fiber	compared	to	the	HCS	diet.
one could hypothesize that the diarrhoea observed in all dogs fed the HPgM diet 
was probably associated with the quality and increased amounts of protein being 
available for the fermentation by the intestinal microbiota due to the inability of the 
host to adjust pancreatic protease secretion when on a high protein diet for three 
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weeks. It is possible that longer periods of feeding this diet could generate an adaptive 
response in the pancreas of the host. An early study in rats concluded that the 
adaptation time of the rat pancreas to a protein-rich diet is shorter (approximately 
five	days)	than	for	a	carbohydrate-rich	diet	(approximately	up	to	10	days),	which	
was possibly due to different mechanisms involved in the adaptive regulation of 
pancreatic protein synthesis (Lahaie & Dagorn 1981). Alternatively, the diarrhoea 
could be due to the lower levels of carbohydrates that enter the large intestine, 
which lead to the abundance of bacteria belonging to the order of Fusobacteriales. 
It is known, that Fusobacteria could produce branched VFA and valeric acid from 
protein break-down products (Resmer & White 2011). Moreover, some Fusobacteria 
can	act	as	pathogens	that	may	cause	intestinal	inflammation,	which	in	addition	to	
diarrhoea would result in increased faecal calprotectin levels. Therefore, valerate 
and calprotectin would be expected to be correlated as was reported in Study II.
5.2.3 dry commercIal dIet
The DC diet was more versatile in terms of available substrates for various 
bacterial types, thus the sequence diversity of faecal samples found in Study I 
in the DC diet was generally higher, when compared to those of the HCS and 
HPGM	 diets.	 Consequently,	 the	 sequences	 were	 classified	 into	 four	 different	
orders of which Lactobacillales and Bacteroidales were completely absent in faecal 
samples for the HCS and HPgM treatments. The DC diet sample showed a high 
abundance of representatives of orders Clostridiales (families Lachnospiraceae 
and Peptostreptococcaceae), Lactobacillales (family Streptococcaceae) and 
Coriobacteriales (family Coriobacteriaceae) and the presence of representatives 
of the order Bacteroidales (family Prevotellaceae).
Interestingly, all sequences of faecal DNA for all diets in fraction 14 in Study 
I belonged to the order Coriobacteriales (Figure 4), which may be indicative of a 
healthy gI microbiota of a dog. A high abundance of one species (i.e., Collinsella 
aerofaciens), which belongs to the order Coriobacteriales has been associated 
with a lowered risk of colon cancer and IBD in humans (Moore & Moore 1995; 
Willing et al. 2010). Bacteria that belong to the order Coriobacteriales have been 
reported only a few times in canine research (garcia-Mazcorro et al. 2011; Handl 
et al. 2011; Wakshlag et al. 2011). Coriobacteriales were also found to be more 
abundant than previously reported with conventional sequencing studies in human 
faecal samples (Krogius-Kurikka et al. 2009). This is most probably due to the fact 
that	those	sequencing	studies	were	carried	out	without	%G+C	fractioning.	In	such	
a case the fractionation of the total faecal DNA preparations minimizes PCR and 
cloning-derived bias, which is common in multi-template sequencing studies. In 
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other	words,	fractionation	facilitates	the	amplification	and	subsequent	cloning	of	
species	with	high	G+C	contents	from	diverse	microbial	communities	(Apajalahti	
et al. 2001; Apajalahti et al. 2002). 
No Bifidobacterium was found in Study I (Figure 8), which agrees with the 
finding	of	an	earlier	study	(Greetham	et	al.	2002).	However,	many	other	studies	
have	found	bifidobacteria	in	dogs	(Buddington	2003a;	Mentula	et	al.	2005;	Handl	
et al. 2011; Beloshapka et al. 2013). It	is	possible	that	bifidobacteria	were	not	part	
of the predominant intestinal microbiota of the dogs in Study I. Another potential 
reason for this unanticipated result may be that the universal 16S rRNA gene-
targeted	primer	pair	contained	mismatches	to	many	bifidobacterial species, which 
may	lead	to	significant	underestimation	of	bacteria	belonging	to	this	genus.
figure 8. Phylogenetic analysis of fraction 5, 10 and 14 sequences in the faeces of five healthy dogs fed 
DC, HPGM and HCS diets (I).
Clostridiales and Coriobacteriales reported in Study I were the most prevalent 
bacterial orders in the faecal samples of all dietary groups (Figure 8).  Fusobacteriales 
and Bacteroidales were discovered to be the most representative orders in the canine 
colon in a study by Suchodolski and co-workers (2008a). It is noteworthy, however, 
that	only	three	%G+C	fractions	were	analyzed	in	the	present	study,	which	showed	
the most pronounced alterations between the dietary groups. Thus, the rationale 
in this study was not to obtain an overall picture of the canine faecal microbiota 
but to discover the dietary effects on the microbial community structure in the 
lower intestine. 
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5.3 ValIdatIon of rIas for the measurement of ctlI  
 and cplI In jejunal fluId and faecal samples (III)
The	analytical	validation	of	two	RIAs	for	the	quantification	of	cTLI	and	cPLI	in	jejunal	
fluid	and	faecal	specimens	were	needed	as	they	were	a	prelude	to	investigate	further	
the	cTLI	and	cPLI	concentrations	in	the	jejunal	fluid	of	the	small	intestine	and	also	
in the faecal samples of healthy dogs fed diets of various compositions (Study IV). 
It has been stated that the mean recovery of the observed-to-expected ratios for 
linearity and spiking recovery should be ideally between 80-120% (Valentin et al. 
2011).	In	the	present	study,	the	means	for	jejunal	fluid	and	faecal	extracts	of	cTLI	
and cPLI concentrations for both linearity and spiking recovery were between 92.7 
and 102.0%, which falls into the acceptable range of an analytical assay validation. 
The cTLI, linearity and spiking recovery in a few cases revealed that the observed-
to-expected ratios were between 74.6 and 80.0%. The occurrence of single lower 
observed-to-expected ratios might be possible due to cTLI concentrations at the 
lower and/or higher end of the calibration curve, which are areas in which the 
assay can lose some precision. However, linearity and spiking recovery the mean 
percentage for observed-to-expected ratios were close to 100%. Furthermore, it 
has been documented that the CV should be ideally < 15% with regard to intra-and 
inter-assay variability (Valentin et al. 2011). The results of the Study III showed that 
the	CV	for	both	assay	and	all	samples	were	≤	10.8%	which	falls	into	the	acceptable	
range for analytical assay validation purposes.
The validation parameters, repeatability and reproducibility showed that 
concentrations	of	cTLI	and	cPLI	in	jejunal	fluid	and	faecal	extracts	varied	among	
the	five	 individual	apparently	healthy	Beagle	dogs.	For	 instance,	 the	variability	
among	five	dogs	for	jejunal	fluid	cPLI	concentrations	ranged	from	143.9	to	440.7	
μg/L	(Table	10).	Explanations	for	this	finding	could	be	due	to	the	differences	in	
dietary compositions of the diets fed in this study and the possible differences 
in gastrointestinal health among these dogs. The fatty acid content of food has 
been shown to vary depending on the structure  such as between canned diets 
vs. dry food (Zentek et al. 2004) and the dietary fat content is a major factor that 
influences	enzyme	concentrations	in	exocrine	pancreatic	secretions	(Faichney	et	
al. 1981). Moreover, chronic ingestion of a high fat diet has been associated with 
hyperlipidaemia (Serisier et al. 2008), which may lead to complications such as 
pancreatitis, obesity, non-insulin-dependent diabetes mellitus or other disorders in 
dogs (Feldman & Nelson 2003; Jeusette et al. 2005; Johnson 2005; Steiner et al. 
2008). However, individual variations in enzyme secretion or enzyme degradation 
during the intestinal passage might also be possible reasons for the observed 
differences. The different diets i.e., DC, HCS, HPgM formulations that all the dogs 
received	at	the	time	of	faecal	sampling	could	influence	the	concentrations	of	cTLI	
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and	cPLI	in	jejunal	fluid	and	faecal	extracts.	The	results	obtained	from	Study	IV	
show	that	the	concentrations	of	cTLI	and	cPLI	in	jejunal	fluid	and	faecal	samples	
were decreased during the HCS and HPgM dietary periods. The results obtained 
in study IV suggest that dogs have only limited capacity for adaptive change of their 
pancreatic	enzyme	profiles.	Further,	the	activity	or	concentrations	of	the	pancreatic	
enzymes	in	serum	and	faeces	do	not	appear	to	reflect	jejunal	conditions.	
Correlations between observed and expected cTLI and cPLI concentrations 
in	jejunal	fluid	and	faecal	specimens	in	Study	III	(e.g.	dilutional	parallelism	and	
spiking recovery) were obtained, which is an alternative valid approach of showing 
the	relationship	of	cTLI	and	cPLI	concentrations	in	jejunal	fluid	and	faeces.	The	
Spearman	rank	sum	correlation	coefficient	(ρ)	was	not	significantly	different	between	
observed	and	expected	cTLI	and	cPLI	concentrations	in	jejunal	fluid	extracts	when	
compared to faecal extracts (data not shown), which indicates that the cTLI and 
cPLI concentrations were not adversely affected by the specimen type.
Conclusions  
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6 conclusions
The major conclusions of the research work presented in this thesis are:
I According to previous 16S rRNA-gene sequencing studies, all bacterial clusters 
discovered here have been reported as representative of normal gI tract microbiota 
of canines. The HPgM diet favoured representatives of the order Fusobacteriales 
and	these	Gram-negative	bacteria	may	be	associated	with	the	elevated	inflammation	
status	that	was	observed.	The	%G+C	profiling	method	in	combination	with	more	
intensive molecular methods such as cloning and sequencing provided completely 
new knowledge about the complex canine intestinal microbiota due to its 
nonselective nature.
II The diarrhoea observed in all dogs fed the HPgM diet was probably associated 
with the quality and increased amounts of protein or the decreased amounts of 
carbohydrate, available for the fermentation by the intestinal microbiota. This 
phenomenon was due to the inability of the host to adequately adjust pancreatic 
enzyme secretion within three weeks. Any of these mechanisms could lead to 
diarrhoea being mediated by changes in the intestinal microbiota. one such 
mechanism is the increased levels of Fusobacteriales and their metabolic activity, 
which gave rise to increased levels of valeric acid. Such changes could possibly lead 
to	intestinal	mucosal	inflammation	and	increased	levels	of	canine	faecal	calprotectin.
 
III The two RIAs evaluated were sensitive, linear, accurate, repeatable and 
reproducible	for	the	quantification	of	cTLI	and	cPLI	in	extracts	of	jejunal	fluid	or	
faeces taken from dogs. The availability and use of these assays may facilitate the 
investigation	of	cTLI	and	cPLI	concentrations	in	jejunal	fluid	and	faecal	extracts	
from dogs in response to changes in dietary components, such as protein, fat or 
carbohydrates, and/or in dogs with various gastrointestinal diseases.
IV Dogs seem to have only a very limited ability to adjust their exocrine pancreatic 
secretions	of	amylase,	pancreatic	specific	lipase,	trypsin	and	elastase	in	response	to	
being fed three different diets, for over a period of three weeks. This lack of adaption 
can lead to an increase in the amounts of undigested macronutrients entering the 
colon, which provides more nutrients for colonic microbiota. A high protein diet 
might even lead to diarrhoea occurring.
75
Future aspects
7 futurE aspEcts
The recent application of culture-independent molecular approaches has revealed 
how little knowledge there is about the intestinal microbiota in health and disease. 
Even less is known about the metabolic activity of the intestinal microbiome and 
its relationship to diet. The research described in this dissertation was focused on 
the	association	between	diet,	intestinal	bacteria,	host-inflammation	and	pancreatic	
adaptation in laboratory Beagle dogs. New insight was provided in the impact of 
diet	on	the	intestinal	microbiota	and	its	link	with	inflammation.	However,	as	the	
used Beagle dogs are laboratory model animals, it would be important to extend 
these	findings	to	other	dogs	that	are	housed	in	a	more	natural	environment.	It	is	
known that research colony dogs do not resemble pet dogs in their environment, 
and differ in their intestinal bacterial microbiota (Batt 1996; Suchodolski 2011; 
Handl et al. 2013), and behaviour (e.g. coprophagy). Selecting healthy and diseased 
pet	dogs	(e.g.	tylosin-responsive	diarrhoea,	inflammatory	bowel	diseases)	on	raw	
meat based diets and/or processed commercial diets for future research would 
make the results and conclusions more widely applicable than currently possible. 
However, when planning such studies, a variety of factors such as costs, time, owner 
allowance and cooperation in long term, different environments and diets need to 
be	taken	into	consideration,	since	they	can	influence	the	outcome	of	such	studies.	
Another aspect that will deserve future attention relates to the methodology of the 
molecular approaches. Notably, sequence-based methods are very rapidly developing 
and are game-changers. The decreasing costs of next generation sequencing will 
make deep phylogenetic and even metagenomic analysis for standard experiments 
feasible in the near future. Therefore, the methods used during the research for this 
thesis, would most probably need to be adapted. The strategy of selective sequencing 
of differential gC fractions and pooling samples from 5 dogs for each diet was 
based on optimizing the detection of differences between diets and the cost of 
sequencing. It is important to note that improved approaches should not change the 
final	outcome	of	the	experiments	and	it	is	expected	that	the	large	impact	of	the	diet	
on the intestinal microbiota will remain.  However, a more detailed picture could be 
obtained when the dog samples would not have been pooled and the clone-based 
approaches would be replaced by direct next generation sequencing approaches. 
The assays of pancreatic enzyme/zymogen used in the research for this thesis 
covered the majority of different functional groups. However, it would have been 
ideal to be able to determine not only the immunoreactivity but also the activity 
of each enzyme. This would add currently still missing knowledge about the 
relationship between intraluminal and fecal activity of pancreatic enzymes and their 
Future aspects
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concentration as measured by determining immunoreactivities. Future research in 
canine patients with chronic enteropathies should test the hypothesis that dietary 
protein content could cause a shift in intestinal microbiota, especially increased 
levels of Fusobacteria, and that such a shift might be associated with mucosal 
inflammation	either	due	to	direct	effects	of	the	bacteria	or	due	to	their	metabolic	
activity. For this purpose, more detailed and higher throughput methodologies 
are required, e.g. microarray technology, next generation sequencing of DNA and 
transcripts of microbiota and hosts (including genotyping based on the dog genome), 
and metabolomic analyses with special attention for the combination of a host 
transcriptome and metabolome.
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